Extracellular	extracellular	JJ	O
acidity	acidity	NN	O
is	be	VBZ	O
a	a	DT	O
common	common	JJ	O
phenotype	phenotype	NN	O
of	of	IN	O
malignant	malignant	JJ	O
tumours	tumour	NNS	O
due	due	IN	O
to	to	IN	O
the	the	DT	O
âWarburg	âWarburg	NNP	O
effectâ.	effectâ.	NNP	O
As	as	IN	O
a	a	DT	O
consequence	consequence	NN	O
,	,	,	O
the	the	DT	O
anaerobic	anaerobic	JJ	O
metabolism	metabolism	NN	O
of	of	IN	O
glucose	glucose	NN	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
triggered	trigger	VBN	O
by	by	IN	O
hypoxia	hypoxia	NNP	O
,	,	,	O
leads	lead	VBZ	O
to	to	IN	O
a	a	DT	O
massive	massive	JJ	O
accumulation	accumulation	NN	O
of	of	IN	O
lactic	lactic	JJ	O
acid	acid	NN	O
and	and	CC	O
H+	h+	ADD	O
within	within	IN	O
the	the	DT	O
cytoplasm	cytoplasm	NN	O
and	and	CC	O
in	in	IN	O
the	the	DT	O
extracellular	extracellular	JJ	O
microenvironment	microenvironment	JJ	B
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
the	the	DT	O
extracellular	extracellular	JJ	O
acidity	acidity	NN	O
induces	induce	VBZ	O
a	a	DT	O
selective	selective	JJ	O
pressure	pressure	NN	O
leading	lead	VBG	O
to	to	IN	O
the	the	DT	O
clonal	clonal	JJ	O
selection	selection	NN	O
of	of	IN	O
cancer	cancer	NN	O
cells	cell	NNS	O
that	that	WDT	O
can	can	MD	O
survive	survive	VB	O
in	in	IN	O
such	such	PDT	O
a	a	DT	O
hostile	hostile	JJ	O
condition	condition	NN	B
.	.	.	O

Cancer	cancer	NN	O
cells	cell	NNS	O
survive	survive	VBP	O
and	and	CC	O
proliferate	proliferate	VBP	O
thanks	thank	NNS	O
to	to	IN	O
a	a	DT	O
series	series	NN	O
of	of	IN	O
innate	innate	JJ	O
mechanism	mechanism	NN	O
conceivably	conceivably	RB	O
common	common	JJ	O
to	to	IN	O
all	all	DT	O
malignant	malignant	JJ	O
tumours	tumour	NNS	B
.	.	.	O

Among	among	IN	O
these	these	DT	O
,	,	,	O
the	the	DT	O
proton	proton	NNP	O
pumps	pump	VBZ	O
play	play	VBP	O
a	a	DT	O
crucial	crucial	JJ	O
role	role	NN	O
,	,	,	O
reducing	reduce	VBG	O
intracellular	intracellular	JJ	O
pH	pH	NNP	O
and	and	CC	O
acidifying	acidify	VBG	O
the	the	DT	O
extracellular	extracellular	JJ	O
environment	environment	NN	B
,	,	,	B
,	,	,	B
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
tumour	tumour	NN	O
cells	cell	NNS	O
up	up	IN	O
-	-	HYPH	O
regulate	regulate	NN	O
proton	proton	NNP	O
exchangers	exchanger	NNS	O
and	and	CC	O
transporters	transporter	NNS	O
throwing	throw	VBG	O
out	out	RP	O
excess	excess	JJ	O
protons	proton	NNS	O
through	through	IN	O
Vacuolar	Vacuolar	NNP	O
ATPase	ATPase	NNP	O
,	,	,	O
Na+/Hâ+âexchanger	Na+/Hâ+âexchanger	NNP	O
,	,	,	O
monocarboxylate	monocarboxylate	NN	O
transporters	transporter	NNS	O
,	,	,	O
cotransporter	cotransporter	NN	O
sodium	sodium	NN	O
bicarbonate	bicarbonate	NN	O
,	,	,	O
and	and	CC	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	VBP	O
9	9	CD	B
,	,	,	B
.	.	.	O

Chemoresistance	chemoresistance	NN	O
of	of	IN	O
cancers	cancer	NNS	O
and	and	CC	O
the	the	DT	O
increase	increase	NN	O
in	in	IN	O
exosome	exosome	JJ	O
release	release	NN	O
are	be	VBP	O
two	two	CD	O
well	well	RB	O
-	-	HYPH	O
known	know	VBN	O
effects	effect	NNS	O
of	of	IN	O
the	the	DT	O
extracellular	extracellular	JJ	O
acidification	acidification	NN	B
.	.	.	O

Exosomes	exosome	NNS	O
are	be	VBP	O
extracellular	extracellular	NNP	O
nanovesicles	nanovesicle	NNS	O
of	of	IN	O
40â180ânm	40â180ânm	CD	O
secreted	secrete	VBN	O
by	by	IN	O
all	all	DT	O
cells	cell	NNS	O
and	and	CC	O
capable	capable	JJ	O
of	of	IN	O
modulating	modulate	VBG	O
physiological	physiological	JJ	O
or	or	CC	O
pathological	pathological	JJ	O
processes	process	NNS	O
,	,	,	O
including	include	VBG	O
tumour	tumour	NN	O
progression	progression	NN	O
,	,	,	O
through	through	IN	O
transmitting	transmit	VBG	O
into	into	IN	O
target	target	NN	O
cells	cell	NNS	O
their	-PRON-	PRP$	O
cargo	cargo	NN	B
.	.	.	O

Exosomes	exosome	NNS	O
are	be	VBP	O
involved	involve	VBN	O
in	in	IN	O
a	a	DT	O
broad	broad	JJ	O
panel	panel	NN	O
of	of	IN	O
cellular	cellular	JJ	O
phenomena	phenomenon	NNS	O
,	,	,	O
including	include	VBG	O
intercellular	intercellular	JJ	O
communication	communication	NN	O
,	,	,	O
elimination	elimination	NN	O
of	of	IN	O
toxic	toxic	JJ	O
substances	substance	NNS	O
and	and	CC	O
drug	drug	NN	O
delivery	delivery	NN	B
,	,	,	B
,	,	,	B
,	,	,	B
.	.	.	O

The	the	DT	O
acid	acid	JJ	O
release	release	NN	O
of	of	IN	O
the	the	DT	O
exosomes	exosome	NNS	O
is	be	VBZ	O
key	key	JJ	O
in	in	IN	O
tumour	tumour	NN	O
growth	growth	NN	O
,	,	,	O
tumour	tumour	NN	O
progression	progression	NN	O
and	and	CC	O
metastasis	metastasis	NN	B
,	,	,	B
,	,	,	B
.	.	.	O

High	high	JJ	O
plasmatic	plasmatic	JJ	O
levels	level	NNS	O
of	of	IN	O
extracellular	extracellular	JJ	O
vesicles	vesicle	NNS	O
are	be	VBP	O
related	relate	VBN	O
with	with	IN	O
the	the	DT	O
tumour	tumour	NN	O
mass	mass	NN	B
,	,	,	B
.	.	.	O

It	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
demonstrated	demonstrate	VBN	O
that	that	IN	O
,	,	,	O
independently	independently	RB	O
from	from	IN	O
the	the	DT	O
tumour	tumour	NN	O
histotype	histotype	NN	O
,	,	,	O
the	the	DT	O
tumour	tumour	NN	O
cell	cell	NN	O
lines	line	NNS	O
cultured	culture	VBN	O
at	at	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
released	release	VBD	O
significantly	significantly	RB	O
higher	high	JJR	O
levels	level	NNS	O
of	of	IN	O
exosomes	exosome	NNS	O
as	as	IN	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
same	same	JJ	O
cells	cell	NNS	O
cultured	culture	VBN	O
at	at	IN	O
physiological	physiological	JJ	O
pH	pH	NNP	B
,	,	,	B
.	.	.	O

Recently	recently	RB	O
,	,	,	O
it	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
shown	show	VBN	O
that	that	IN	O
the	the	DT	O
microenvironmental	microenvironmental	JJ	O
low	low	NN	O
pH	pH	NNP	O
was	be	VBD	O
consistent	consistent	JJ	O
with	with	IN	O
a	a	DT	O
change	change	NN	O
in	in	IN	O
exosome	exosome	JJ	O
cargo	cargo	NN	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
with	with	IN	O
some	some	DT	O
tumour	tumour	NN	O
biomarkers	biomarker	NNS	O
such	such	JJ	O
as	as	IN	O
Prostate	Prostate	NNP	O
Specific	Specific	NNP	O
Antigen	Antigen	NNP	O
and	and	CC	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
IX	IX	NNP	B
,	,	,	B
.	.	.	O

CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
a	a	DT	O
zinc	zinc	NN	O
metalloenzyme	metalloenzyme	NNS	O
belonging	belong	VBG	O
to	to	IN	O
a	a	DT	O
broader	broad	JJR	O
group	group	NN	O
of	of	IN	O
15	15	CD	O
isoforms	isoform	NNS	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
catalysis	catalysis	NN	O
of	of	IN	O
carbon	carbon	NN	O
dioxide	dioxide	NN	O
hydration	hydration	NN	O
to	to	TO	O
bicarbonate	bicarbonate	VB	O
and	and	CC	O
proton	proton	JJ	O
.	.	.	O

Among	among	IN	O
these	these	DT	O
isoforms	isoform	NNS	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
has	have	VBZ	O
high	high	JJ	O
clinical	clinical	JJ	O
relevance	relevance	NN	O
in	in	IN	O
cancer	cancer	NN	O
therapy	therapy	NN	O
since	since	IN	O
it	-PRON-	PRP	O
is	be	VBZ	O
implicated	implicate	VBN	O
in	in	IN	O
tumorigenesis	tumorigenesis	NN	B
,	,	,	B
,	,	,	B
and	and	CC	O
considered	consider	VBN	O
a	a	DT	O
marker	marker	NN	O
of	of	IN	O
tumour	tumour	NN	O
hypoxia	hypoxia	NN	B
.	.	.	O

CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
overexpressed	overexpresse	VBN	O
in	in	IN	O
a	a	DT	O
large	large	JJ	O
number	number	NN	O
of	of	IN	O
solid	solid	JJ	O
tumours	tumour	NNS	O
,	,	,	O
whereas	whereas	IN	O
its	-PRON-	PRP$	O
expression	expression	NN	O
in	in	IN	O
normal	normal	JJ	O
tissues	tissue	NNS	O
is	be	VBZ	O
quite	quite	RB	O
limited	limited	JJ	O
,	,	,	O
suggesting	suggest	VBG	O
its	-PRON-	PRP$	O
role	role	NN	O
as	as	IN	O
valuable	valuable	JJ	O
tumour	tumour	NN	O
biomarker	biomarker	NN	O
.	.	.	O

Furthermore	furthermore	RB	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
has	have	VBZ	O
been	be	VBN	O
validated	validate	VBN	O
as	as	IN	O
a	a	DT	O
target	target	NN	O
of	of	IN	O
new	new	JJ	O
therapies	therapy	NNS	O
against	against	IN	O
hypoxic	hypoxic	JJ	O
tumours	tumour	NNS	O
with	with	IN	O
one	one	CD	O
sulphonamide	sulphonamide	JJ	O
inhibitor	inhibitor	NN	O
in	in	IN	O
Phase	Phase	NNP	O
Ib	Ib	NNP	O
/	/	SYM	O
II	II	NNP	O
clinical	clinical	JJ	O
trials	trial	NNS	B
,	,	,	B
,	,	,	B
,	,	,	B
.	.	.	O

Indeed	indeed	RB	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
the	the	DT	O
most	most	RBS	O
widely	widely	RB	O
expressed	express	VBN	O
gene	gene	NN	O
in	in	IN	O
response	response	NN	O
to	to	IN	O
hypoxia	hypoxia	NNP	O
,	,	,	O
playing	play	VBG	O
a	a	DT	O
pivotal	pivotal	JJ	O
role	role	NN	O
in	in	IN	O
tumour	tumour	NN	O
pH	pH	NNP	O
regulation	regulation	NN	B
,	,	,	B
,	,	,	B
,	,	,	B
;	;	:	O
thus	thus	RB	O
conferring	confer	VBG	O
to	to	IN	O
cancer	cancer	NN	O
cells	cell	NNS	O
a	a	DT	O
survival	survival	NN	O
advantage	advantage	NN	O
in	in	IN	O
hypoxic	hypoxic	JJ	O
and	and	CC	O
acidic	acidic	JJ	O
microenvironments	microenvironment	NNS	B
.	.	.	O

Thus	thus	RB	O
,	,	,	O
it	-PRON-	PRP	O
is	be	VBZ	O
clear	clear	JJ	O
that	that	IN	O
the	the	DT	O
acidic	acidic	JJ	O
microenvironment	microenvironment	NN	O
induces	induce	VBZ	O
the	the	DT	O
up	up	JJ	O
-	-	HYPH	O
regulation	regulation	NN	O
of	of	IN	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
in	in	IN	O
both	both	CC	O
tumour	tumour	NN	O
cells	cell	NNS	B
,	,	,	B
and	and	CC	O
tumour	tumour	NN	O
released	release	VBN	O
exosomes	exosome	NNS	B
.	.	.	O

However	however	RB	O
,	,	,	O
the	the	DT	O
possibility	possibility	NN	O
that	that	WDT	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
in	in	IN	O
cancer	cancer	NN	O
cell	cell	NN	O
-	-	HYPH	O
derived	derive	VBN	O
exosomes	exosome	NNS	O
could	could	MD	O
represent	represent	VB	O
a	a	DT	O
new	new	JJ	O
valuable	valuable	JJ	O
tumour	tumour	NN	O
marker	marker	NN	O
has	have	VBZ	O
not	not	RB	O
yet	yet	RB	O
been	be	VBN	O
tested	test	VBN	O
in	in	IN	O
clinical	clinical	JJ	O
samples	sample	NNS	O
.	.	.	O

In	in	IN	O
the	the	DT	O
present	present	JJ	O
study	study	NN	O
,	,	,	O
the	the	DT	O
expression	expression	NN	O
and	and	CC	O
the	the	DT	O
activity	activity	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
were	be	VBD	O
detected	detect	VBN	O
in	in	IN	O
the	the	DT	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
obtained	obtain	VBN	O
from	from	IN	O
patients	patient	NNS	O
affected	affect	VBN	O
and	and	CC	O
non	non	JJ	O
-	-	VBN	O
affected	affect	VBN	O
by	by	IN	O
prostate	prostate	NN	O
carcinoma	carcinoma	NN	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
behaviour	behaviour	NN	O
was	be	VBD	O
correlated	correlate	VBN	O
to	to	IN	O
the	the	DT	O
intraluminal	intraluminal	JJ	O
pH	pH	NNP	O
of	of	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
in	in	IN	O
both	both	DT	O
patients	patient	NNS	O
and	and	CC	O
controls	control	NNS	O
.	.	.	O

Our	-PRON-	PRP$	O
results	result	NNS	O
indicate	indicate	VBP	O
that	that	IN	O
exosomal	exosomal	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
showed	show	VBD	O
a	a	DT	O
higher	high	JJR	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
when	when	WRB	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
controls	control	NNS	O
,	,	,	O
which	which	WDT	O
were	be	VBD	O
consistent	consistent	JJ	O
with	with	IN	O
a	a	DT	O
lower	low	JJR	O
intraluminal	intraluminal	JJ	O
pH	ph	NN	O
of	of	IN	O
the	the	DT	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
of	of	IN	O
PCa	PCa	NNS	O
.	.	.	O

These	these	DT	O
data	datum	NNS	O
suggest	suggest	VBP	O
that	that	IN	O
exosomal	exosomal	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
might	may	MD	O
be	be	VB	O
an	an	DT	O
interesting	interesting	JJ	O
biomarker	biomarker	NN	O
of	of	IN	O
cancer	cancer	NN	O
progression	progression	NN	O
.	.	.	O

Human	human	JJ	O
plasma	plasma	NN	O
samples	sample	NNS	O
were	be	VBD	O
collected	collect	VBN	O
from	from	IN	O
EDTA	EDTA	NNP	O
-	-	HYPH	O
treated	treat	VBN	O
whole	whole	JJ	O
blood	blood	NN	O
,	,	,	O
5âml	5âml	CD	O
into	into	IN	O
BD	BD	NNP	O
VacutainerÂ	vacutainerâ	FW	O
®	®	NNP	O
K3-EDTA	k3-edta	NN	O
-	-	HYPH	O
coated	coat	VBN	O
collection	collection	NN	O
tubes	tube	NNS	O
,	,	,	O
from	from	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
patients	patient	NNS	O
nâ=â8	nâ=â8	NNP	O
and	and	CC	O
healthy	healthy	JJ	O
donors	donor	NNS	O
used	use	VBN	O
as	as	IN	O
controls	control	NNS	O
nâ=â8	nâ=â8	NNP	O
attending	attend	VBG	O
to	to	IN	O
department	department	NN	O
of	of	IN	O
Urological	Urological	NNP	O
Sciences	Sciences	NNPS	O
,	,	,	O
Policlinico	Policlinico	NNP	O
Umberto	Umberto	NNP	O
I	I	NNP	O
,	,	,	O
Sapienza	Sapienza	NNP	O
University	University	NNP	O
of	of	IN	O
Rome	Rome	NNP	O
,	,	,	O
Italy	Italy	NNP	O
.	.	.	O

The	the	DT	O
study	study	NN	O
was	be	VBD	O
approved	approve	VBN	O
by	by	IN	O
the	the	DT	O
ethics	ethic	NNS	O
committee	committee	NN	O
of	of	IN	O
IstitutoSuperiore	IstitutoSuperiore	NNP	O
di	di	NNP	O
SanitÃ	SanitÃ	NNP	O
on	on	IN	O
18/04/2017	18/04/2017	CD	O
.	.	.	O

The	the	DT	O
study	study	NN	O
was	be	VBD	O
conducted	conduct	VBN	O
in	in	IN	O
accordance	accordance	NN	O
with	with	IN	O
the	the	DT	O
current	current	JJ	O
International	International	NNP	O
Conference	Conference	NNP	O
on	on	IN	O
Harmonisation	Harmonisation	NNP	O
guidelines	guideline	NNS	O
for	for	IN	O
Good	Good	NNP	O
Clinical	Clinical	NNP	O
Practice	Practice	NNP	O
and	and	CC	O
the	the	DT	O
principles	principle	NNS	O
of	of	IN	O
the	the	DT	O
Declaration	Declaration	NNP	O
of	of	IN	O
Helsinki	Helsinki	NNP	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
participants	participant	NNS	O
provided	provide	VBD	O
written	write	VBN	O
informed	informed	JJ	O
consent	consent	NN	O
.	.	.	O

The	the	DT	O
study	study	NN	O
population	population	NN	O
included	include	VBD	O
the	the	DT	O
prostate	prostate	NN	O
cancer	cancer	NN	O
group	group	NN	O
and	and	CC	O
the	the	DT	O
healthy	healthy	JJ	O
donors	donor	NNS	O
group	group	NN	O
.	.	.	O

The	the	DT	O
PCa	PCa	NNP	O
group	group	NN	O
consisted	consist	VBD	O
of	of	IN	O
8	8	CD	O
male	male	JJ	O
individuals	individual	NNS	O
consecutively	consecutively	RB	O
referred	refer	VBN	O
to	to	IN	O
department	department	NN	O
of	of	IN	O
Urological	Urological	NNP	O
Sciences	Sciences	NNPS	O
,	,	,	O
aged	age	VBN	O
from	from	IN	O
45	45	CD	O
to	to	IN	O
75âyears	75âyears	CD	O
,	,	,	O
with	with	IN	O
a	a	DT	O
histologically	histologically	RB	O
confirmed	confirm	VBN	O
diagnosis	diagnosis	NN	O
of	of	IN	O
prostate	prostate	NN	O
adenocarcinoma	adenocarcinoma	NN	O
.	.	.	O

None	none	NN	O
of	of	IN	O
cases	case	NNS	O
were	be	VBD	O
submitted	submit	VBN	O
to	to	TO	O
androgen	androgen	VB	O
deprivation	deprivation	NN	O
therapies	therapy	NNS	O
or	or	CC	O
other	other	JJ	O
therapies	therapy	NNS	O
that	that	WDT	O
can	can	MD	O
influence	influence	VB	O
PSA	PSA	NNP	O
determination	determination	NN	O
.	.	.	O

All	all	DT	O
cases	case	NNS	O
were	be	VBD	O
stratified	stratify	VBN	O
in	in	IN	O
risk	risk	NN	O
classes	class	NNS	O
on	on	IN	O
the	the	DT	O
basis	basis	NN	O
of	of	IN	O
total	total	JJ	O
PSA	PSA	NNP	O
levels	level	NNS	O
>	>	XX	O
4.5âng	4.5âng	NNP	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
Gleason	Gleason	NNP	O
score	score	NN	O
and	and	CC	O
clinical	clinical	JJ	O
stage	stage	NN	O
.	.	.	O

The	the	DT	O
control	control	NN	O
group	group	NN	O
consisted	consist	VBD	O
of	of	IN	O
8	8	CD	O
male	male	JJ	O
individuals	individual	NNS	O
consecutively	consecutively	RB	O
referred	refer	VBD	O
to	to	IN	O
Urological	Urological	NNP	O
Sciences	Sciences	NNP	O
Department	Department	NNP	O
with	with	IN	O
the	the	DT	O
following	follow	VBG	O
inclusion	inclusion	NN	O
criteria	criterion	NNS	O
:	:	:	O
age	age	NN	O
from	from	IN	O
18	18	CD	O
to	to	IN	O
39âyears	39âyears	CD	O
;	;	:	O
no	no	DT	O
clinical	clinical	JJ	O
evidence	evidence	NN	O
of	of	IN	O
BPH	BPH	NNP	O
or	or	CC	O
PCa	PCa	NNS	O
digital	digital	JJ	O
rectal	rectal	JJ	O
examination	examination	NN	O
and	and	CC	O
ultrasonography	ultrasonography	NNP	O
US	US	NNP	O
;	;	:	O
prostate	prostate	NN	O
volume	volume	NN	O
less	less	JJR	O
than	than	IN	O
30âcc	30âcc	CD	O
;	;	:	O
no	no	DT	O
familiarity	familiarity	NN	O
for	for	IN	O
PCa	PCa	NNS	O
;	;	:	O
no	no	DT	O
therapies	therapy	NNS	O
that	that	WDT	O
can	can	MD	O
influence	influence	VB	O
PSA	PSA	NNP	O
determination	determination	NN	O
.	.	.	O

To	to	TO	O
obtain	obtain	VB	O
exosomes	exosome	NNS	O
from	from	IN	O
plasma	plasma	NN	O
samples	sample	NNS	O
,	,	,	O
EDTA	edta	NN	O
-	-	HYPH	O
treated	treat	VBN	O
blood	blood	NN	O
from	from	IN	O
8	8	CD	O
patients	patient	NNS	O
with	with	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
and	and	CC	O
8	8	CD	O
healthy	healthy	JJ	O
donors	donor	NNS	O
was	be	VBD	O
centrifuged	centrifuge	VBN	O
at	at	IN	O
400âg	400âg	NN	O
for	for	IN	O
20âmin	20âmin	CD	O
.	.	.	O

Plasma	Plasma	NNP	O
was	be	VBD	O
then	then	RB	O
collected	collect	VBN	O
and	and	CC	O
stored	store	VBN	O
at	at	IN	O
â80âÂ	â80âÂ	NNS	O
°	°	NNS	O
C	C	NNP	O
until	until	IN	O
they	-PRON-	PRP	O
will	will	MD	O
be	be	VB	O
analysed	analyse	VBN	O
for	for	IN	O
the	the	DT	O
expression	expression	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
.	.	.	O

Upon	upon	IN	O
thawing	thaw	VBG	O
,	,	,	O
1âml	1âml	CD	O
of	of	IN	O
plasma	plasma	NN	O
samples	sample	NNS	O
was	be	VBD	O
subjected	subject	VBN	O
to	to	IN	O
the	the	DT	O
same	same	JJ	O
centrifugal	centrifugal	JJ	O
procedure	procedure	NN	O
as	as	IN	O
previously	previously	RB	O
described	describe	VBN	B
,	,	,	B
in	in	IN	O
order	order	NN	O
to	to	IN	O
pellet	pellet	JJ	O
exosomes	exosome	NNS	O
.	.	.	O

Plasma	plasma	NN	O
samples	sample	NNS	O
were	be	VBD	O
centrifuged	centrifuge	VBN	O
for	for	IN	O
1âh	1âh	CD	O
30âmin	30âmin	NN	O
at	at	IN	O
110â000âg	110â000âg	CD	O
using	use	VBG	O
a	a	DT	O
Fiberliteâ¢	fiberliteâ¢	NN	O
F50L-24âÃâ1.5	F50L-24âÃâ1.5	NNP	O
Fixed	Fixed	NNP	O
-	-	HYPH	O
Angle	Angle	NNP	O
Rotor	Rotor	NNP	O
,	,	,	O
K	K	NNP	O
-	-	HYPH	O
Factor	Factor	NNP	O
:	:	:	O
33	33	CD	O
in	in	IN	O
Sorvall	Sorvall	NNP	O
WX	WX	NNP	O
Ultracentrifuge	Ultracentrifuge	NNP	O
Series	Series	NNP	O
.	.	.	O

Nanoparticle	nanoparticle	NN	O
tracking	track	VBG	O
analysis	analysis	NN	O
from	from	IN	O
Malvern	Malvern	NNP	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
size	size	NN	O
distribution	distribution	NN	O
and	and	CC	O
concentration	concentration	NN	O
measurements	measurement	NNS	O
of	of	IN	O
exosomes	exosome	NNS	O
samples	sample	NNS	O
in	in	IN	O
liquid	liquid	JJ	O
suspension	suspension	NN	O
from	from	IN	O
the	the	DT	O
properties	property	NNS	O
of	of	IN	O
both	both	DT	O
light	light	NN	O
scattering	scatter	VBG	O
and	and	CC	O
Brownian	brownian	JJ	O
motion	motion	NN	O
.	.	.	O

The	the	DT	O
NanoSight	NanoSight	NNP	O
NS300	NS300	NNP	O
with	with	IN	O
a	a	DT	O
405-nm	405-nm	CD	O
laser	laser	NN	O
instrument	instrument	NN	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
detect	detect	VB	O
nanovesicles	nanovesicle	NNS	O
.	.	.	O

Five	five	CD	O
videos	video	NNS	O
of	of	IN	O
typically	typically	RB	O
60-s	60-s	CD	O
duration	duration	NN	O
were	be	VBD	O
taken	take	VBN	O
.	.	.	O

Data	datum	NNS	O
were	be	VBD	O
analysed	analyse	VBN	O
using	use	VBG	O
the	the	DT	O
NTA	NTA	NNP	O
3.0	3.0	CD	O
software	software	NN	O
which	which	WDT	O
was	be	VBD	O
optimised	optimise	VBN	O
to	to	TO	O
first	first	RB	O
identify	identify	VB	O
and	and	CC	O
then	then	RB	O
track	track	VB	O
each	each	DT	O
particle	particle	NN	O
on	on	IN	O
a	a	DT	O
frame	frame	NN	O
-	-	HYPH	O
by	by	IN	O
-	-	HYPH	O
frame	frame	NN	O
basis	basis	NN	O
.	.	.	O

The	the	DT	O
Brownian	brownian	JJ	O
motion	motion	NN	O
of	of	IN	O
each	each	DT	O
particle	particle	NN	O
was	be	VBD	O
tracked	track	VBN	O
using	use	VBG	O
the	the	DT	O
StokesâEinstein	StokesâEinstein	NNP	O
equation	equation	NN	O
:	:	:	O
DÂ	DÂ	NNP	O
°	°	,	O
=	=	SYM	O
kT/6ÏÎ·r	kt/6ïî·r	NN	O
,	,	,	O
where	where	WRB	O
DÂ	DÂ	NNP	O
°	°	,	O
is	be	VBZ	O
the	the	DT	O
diffusion	diffusion	NN	O
coefficient	coefficient	NN	O
,	,	,	O
kT/6ÏÎ·râ=âf0	kT/6ÏÎ·râ=âf0	NNP	O
is	be	VBZ	O
the	the	DT	O
frictional	frictional	JJ	O
coefficient	coefficient	NN	O
of	of	IN	O
the	the	DT	O
particle	particle	NN	O
,	,	,	O
for	for	IN	O
the	the	DT	O
special	special	JJ	O
case	case	NN	O
of	of	IN	O
a	a	DT	O
spherical	spherical	JJ	O
particle	particle	NN	O
of	of	IN	O
radius	radius	NN	O
r	r	NNP	O
moving	move	VBG	O
with	with	IN	O
uniform	uniform	JJ	O
velocity	velocity	NN	O
in	in	IN	O
a	a	DT	O
continuous	continuous	JJ	O
fluid	fluid	NN	O
of	of	IN	O
viscosity	viscosity	NN	O
Î	Î	NNP	O
·	·	NFP	O
,	,	,	O
k	k	NNP	O
is	be	VBZ	O
Boltzmannâs	boltzmannâs	NN	O
constant	constant	JJ	O
,	,	,	O
and	and	CC	O
T	T	NNP	O
is	be	VBZ	O
the	the	DT	O
absolute	absolute	JJ	O
temperature	temperature	NN	O
.	.	.	O

To	to	TO	O
perform	perform	VB	O
Western	western	JJ	O
blot	blot	NN	O
analysis	analysis	NN	O
,	,	,	O
the	the	DT	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	VBZ	O
pellet	pellet	NNP	O
was	be	VBD	O
resuspended	resuspend	VBN	O
in	in	IN	O
1âml	1âml	CD	O
of	of	IN	O
PBS	PBS	NNP	O
and	and	CC	O
it	-PRON-	PRP	O
was	be	VBD	O
further	further	RB	O
purified	purify	VBN	O
by	by	IN	O
using	use	VBG	O
30	30	CD	O
%	%	NN	O
sucrose	sucrose	NN	O
in	in	IN	O
deuterium	deuterium	NN	O
oxide	oxide	NN	O
density	density	NN	O
gradient	gradient	NN	O
ultracentrifugation	ultracentrifugation	NN	O
for	for	IN	O
18âh	18âh	CD	O
at	at	IN	O
110,000âg	110,000âg	CD	O
,	,	,	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
eliminate	eliminate	VB	O
contaminants	contaminant	NNS	B
,	,	,	B
.	.	.	O

Density	density	NN	O
gradient	gradient	NN	O
ultracentrifugation	ultracentrifugation	NN	O
was	be	VBD	O
performed	perform	VBN	O
by	by	IN	O
using	use	VBG	O
TH-641	TH-641	NNP	O
Rotor	Rotor	NNP	O
.	.	.	O

The	the	DT	O
12	12	CD	O
fractions	fraction	NNS	O
obtained	obtain	VBN	O
were	be	VBD	O
washed	wash	VBN	O
in	in	IN	O
PBS	PBS	NNP	O
for	for	IN	O
1âh	1âh	CD	O
at	at	IN	O
110,000âg	110,000âg	CD	O
and	and	CC	O
then	then	RB	O
were	be	VBD	O
resuspended	resuspend	VBN	O
in	in	IN	O
CHAPS	CHAPS	NNP	O
buffer	buffer	NN	O
1x	1x	NNP	O
for	for	IN	O
subsequent	subsequent	JJ	O
experimental	experimental	JJ	O
analysis	analysis	NN	O
.	.	.	O

Lysates	Lysates	NNPS	O
were	be	VBD	O
prepared	prepare	VBN	O
in	in	IN	O
CHAPS	CHAPS	NNP	O
buffer	buffer	NN	O
10âmM	10âmm	CD	O
Tris	Tris	NNP	O
-	-	HYPH	O
HCl	HCl	NNP	O
,	,	,	O
MgCl2	mgcl2	NN	O
1âmM	1âmm	CD	O
,	,	,	O
EGTA	EGTA	NNP	O
1âmM	1âmm	CD	O
,	,	,	O
CHAPS	CHAPS	NNP	O
0.5	0.5	CD	O
%	%	NN	O
,	,	,	O
glycerol	glycerol	NN	O
10	10	CD	O
%	%	NN	O
,	,	,	O
Î²-mercaptoethanol	î²-mercaptoethanol	NN	O
5âmM	5âmm	CD	O
,	,	,	O
PMSF	PMSF	NNP	O
1âmM	1âmm	CD	O
containing	contain	VBG	O
protease	protease	NN	O
inhibitor	inhibitor	NN	O
cocktail	cocktail	NN	O
.	.	.	O

Exosomes	exosome	NNS	O
lysates	lysate	NNS	O
were	be	VBD	O
subjected	subject	VBN	O
to	to	IN	O
electrophoresis	electrophoresis	NN	O
on	on	IN	O
SDS	SDS	NNP	O
polyacrylamide	polyacrylamide	NN	O
gels	gel	NNS	O
and	and	CC	O
transferred	transfer	VBN	O
to	to	IN	O
nitrocellulose	nitrocellulose	NN	O
membranes	membrane	NNS	O
.	.	.	O

After	after	IN	O
blocking	block	VBG	O
in	in	IN	O
5	5	CD	O
%	%	NN	O
dry	dry	JJ	O
milk	milk	NN	O
in	in	IN	O
PBS	PBS	NNP	O
1X	1x	NN	O
,	,	,	O
membranes	membrane	NNS	O
were	be	VBD	O
hybridised	hybridise	VBN	O
with	with	IN	O
primary	primary	JJ	O
antibodies	antibody	NNS	O
:	:	:	O
M75	M75	NNP	B
,	,	,	O
anti	anti	JJ	O
-	-	NNP	O
CD81	cd81	JJ	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
Alix	alix	JJ	O
mouse	mouse	NN	O
monoclonal	monoclonal	JJ	O
antibodies	antibody	NNS	O
.	.	.	O

After	after	IN	O
incubation	incubation	NN	O
with	with	IN	O
appropriate	appropriate	JJ	O
peroxidase	peroxidase	NN	O
-	-	HYPH	O
conjugated	conjugate	VBN	O
anti	anti	JJ	O
-	-	NN	O
IgG	IgG	NNP	O
,	,	,	O
membranes	membranes	NNP	O
were	be	VBD	O
revealed	reveal	VBN	O
using	use	VBG	O
the	the	DT	O
ECL	ECL	NNP	O
Chemiluminescent	Chemiluminescent	NNP	O
Substrate	Substrate	NNP	O
,	,	,	O
.96	.96	NFP	O
well	well	NN	O
-	-	HYPH	O
plates	plate	NNS	O
were	be	VBD	O
coated	coat	VBN	O
with	with	IN	O
4âÂµg	4ââµg	CD	O
/	/	SYM	O
ml	ml	NN	O
rabbit	rabbit	NN	O
polyclonal	polyclonal	JJ	O
anti	anti	JJ	O
-	-	JJ	O
CD81	cd81	JJ	O
antibody	antibody	NN	O
in	in	IN	O
100âÂµl	100ââµl	CD	O
/	/	SYM	O
well	well	RB	O
of	of	IN	O
PBS	PBS	NNP	O
and	and	CC	O
incubated	incubate	VBD	O
overnight	overnight	RB	O
at	at	IN	O
4âÂ	4ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

After	after	IN	O
3	3	CD	O
washes	wash	NNS	O
with	with	IN	O
PBS	PBS	NNP	O
,	,	,	O
100âÂµl	100ââµl	CD	O
/	/	SYM	O
well	well	NN	O
of	of	IN	O
blocking	block	VBG	O
solution	solution	NN	O
were	be	VBD	O
added	add	VBN	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
for	for	IN	O
1âh	1âh	CD	O
.	.	.	O

Following	follow	VBG	O
3	3	CD	O
washes	wash	NNS	O
in	in	IN	O
PBS	PBS	NNP	O
,	,	,	O
exosomes	exosome	VBZ	O
purified	purify	VBN	O
from	from	IN	O
1âml	1âml	CD	O
of	of	IN	O
plasma	plasma	NN	O
were	be	VBD	O
suspended	suspend	VBN	O
in	in	IN	O
a	a	DT	O
final	final	JJ	O
volume	volume	NN	O
of	of	IN	O
50âÂµl	50ââµl	CD	O
and	and	CC	O
incubated	incubate	VBD	O
overnight	overnight	RB	O
at	at	IN	O
37âÂ	37ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

After	after	IN	O
3	3	CD	O
washes	wash	NNS	O
with	with	IN	O
PBS	PBS	NNP	O
,	,	,	O
M75	M75	NNP	O
mouse	mouse	NN	O
monoclonal	monoclonal	JJ	O
antibody	antibody	NN	B
was	be	VBD	O
added	add	VBN	O
to	to	IN	O
each	each	DT	O
well	well	RB	O
and	and	CC	O
incubated	incubate	VBD	O
for	for	IN	O
1âh	1âh	CD	O
at	at	IN	O
37âÂ	37ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

After	after	IN	O
3	3	CD	O
washes	wash	NNS	O
with	with	IN	O
PBS	PBS	NNP	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
mouse	mouse	JJ	O
HRP	HRP	NNP	O
-	-	HYPH	O
conjugated	conjugate	VBN	O
was	be	VBD	O
incubated	incubate	VBN	O
in	in	IN	O
each	each	DT	O
well	well	NN	O
for	for	IN	O
1âh	1âh	CD	O
at	at	IN	O
RT	RT	NNP	O
.	.	.	O

After	after	IN	O
the	the	DT	O
final	final	JJ	O
3	3	CD	O
washes	wash	NNS	O
with	with	IN	O
PBS	PBS	NNP	O
,	,	,	O
the	the	DT	O
reaction	reaction	NN	O
was	be	VBD	O
developed	develop	VBN	O
with	with	IN	O
Blue	Blue	NNP	O
POD	POD	NNP	O
for	for	IN	O
15âmin	15âmin	CD	O
,	,	,	O
and	and	CC	O
blocked	block	VBD	O
with	with	IN	O
4âN	4ân	CD	O
H2SO4	H2SO4	NNP	O
stop	stop	VB	O
solution	solution	NN	O
.	.	.	O

Optical	optical	JJ	O
densities	density	NNS	O
were	be	VBD	O
recorded	record	VBN	O
at	at	IN	O
450ânm	450ânm	CD	O
.	.	.	O

Exosomes	exosome	NNS	O
were	be	VBD	O
obtained	obtain	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
8	8	CD	O
prostate	prostate	NN	O
cancer	cancer	NN	O
patients	patient	NNS	O
and	and	CC	O
8	8	CD	O
healthy	healthy	JJ	O
donors	donor	NNS	O
.	.	.	O

Exosome	Exosome	NNP	O
extracts	extract	NNS	O
were	be	VBD	O
prepared	prepare	VBN	O
at	at	IN	O
4âÂ	4ââ	CD	O
°	°	NNS	O
C	C	NNP	O
using	use	VBG	O
the	the	DT	O
lysis	lysis	NN	O
buffer	buffer	NN	O
containing	contain	VBG	O
1	1	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
,	,	,	O
10mMTris	10mmtris	CD	O
-	-	HYPH	O
HCl	HCl	NNP	O
,	,	,	O
MgCl2	mgcl2	NN	O
1âmM	1âmm	CD	O
,	,	,	O
EGTA	EGTA	NNP	O
1âmM	1âmm	CD	O
,	,	,	O
CHAPS	CHAPS	NNP	O
0.5	0.5	CD	O
%	%	NN	O
,	,	,	O
glycerol	glycerol	NN	O
10	10	CD	O
%	%	NN	O
,	,	,	O
Î²-mercaptoethanol	î²-mercaptoethanol	NN	O
5âmM	5âmm	CD	O
,	,	,	O
and	and	CC	O
supplemented	supplement	VBN	O
with	with	IN	O
a	a	DT	O
cocktail	cocktail	NN	O
of	of	IN	O
protease	protease	NN	O
inhibitors	inhibitor	NNS	O
.	.	.	O

Aliquots	aliquot	NNS	O
of	of	IN	O
exosomes	exosome	NNS	O
extracts	extract	NNS	O
containing	contain	VBG	O
1âÂµg	1ââµg	CD	O
of	of	IN	O
total	total	JJ	O
protein	protein	NN	O
were	be	VBD	O
used	use	VBN	O
to	to	IN	O
determining	determine	VBG	O
the	the	DT	O
hydratase	hydratase	NN	O
activity	activity	NN	O
.	.	.	O

The	the	DT	O
enzymatic	enzymatic	JJ	O
assay	assay	NN	O
was	be	VBD	O
performed	perform	VBN	O
at	at	IN	O
0âÂ	0ââ	CD	O
°	°	NNP	O
C	C	NNP	O
using	use	VBG	O
CO2	CO2	NNP	O
as	as	IN	O
substrate	substrate	NN	O
following	follow	VBG	O
the	the	DT	O
pH	pH	NNP	O
variation	variation	NN	O
due	due	IN	O
to	to	IN	O
the	the	DT	O
catalysed	catalyse	VBN	O
conversion	conversion	NN	O
of	of	IN	O
CO2	CO2	NNP	O
to	to	TO	O
bicarbonate	bicarbonate	VB	O
.	.	.	O

Bromothymol	bromothymol	JJ	O
blue	blue	NN	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
the	the	DT	O
indicator	indicator	NN	O
of	of	IN	O
pH	pH	NNP	O
variation	variation	NN	O
.	.	.	O

The	the	DT	O
production	production	NN	O
of	of	IN	O
hydrogen	hydrogen	NN	O
ions	ion	NNS	O
during	during	IN	O
the	the	DT	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
reaction	reaction	NN	O
lowers	lower	VBZ	O
the	the	DT	O
pH	pH	NNP	O
of	of	IN	O
the	the	DT	O
solution	solution	NN	O
until	until	IN	O
the	the	DT	O
colour	colour	NN	O
transition	transition	NN	O
point	point	NN	O
of	of	IN	O
the	the	DT	O
dye	dye	NN	O
is	be	VBZ	O
reached	reach	VBN	O
.	.	.	O

The	the	DT	O
time	time	NN	O
required	require	VBN	O
for	for	IN	O
the	the	DT	O
colour	colour	NN	O
change	change	NN	O
is	be	VBZ	O
inversely	inversely	RB	O
related	related	JJ	O
to	to	IN	O
the	the	DT	O
quantity	quantity	NN	O
and	and	CC	O
activity	activity	NN	O
of	of	IN	O
CAs	cas	JJ	O
present	present	JJ	O
in	in	IN	O
the	the	DT	O
sample	sample	NN	O
.	.	.	O

WilburâAnderson	WilburâAnderson	NNP	O
units	unit	NNS	O
were	be	VBD	O
calculated	calculate	VBN	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
following	following	JJ	O
definition	definition	NN	O
:	:	:	O
One	one	CD	O
WilburâAnderson	WilburâAnderson	NNP	O
unit	unit	NN	O
of	of	IN	O
activity	activity	NN	O
is	be	VBZ	O
defined	define	VBN	O
as	as	IN	O
T0âââT)/T	T0âââT)/T	NNP	O
,	,	,	O
where	where	WRB	O
T0	t0	NN	O
and	and	CC	O
T	T	NNP	O
are	be	VBP	O
recorded	record	VBN	O
as	as	IN	O
the	the	DT	O
time	time	NN	O
required	require	VBN	O
for	for	IN	O
the	the	DT	O
pH	pH	NNP	O
to	to	TO	O
drop	drop	VB	O
from	from	IN	O
8.3	8.3	CD	O
to	to	IN	O
the	the	DT	O
transition	transition	NN	O
point	point	NN	O
of	of	IN	O
the	the	DT	O
dye	dye	NN	O
in	in	IN	O
a	a	DT	O
control	control	NN	O
buffer	buffer	NN	O
and	and	CC	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
enzyme	enzyme	NNS	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Enzyme	Enzyme	NNS	O
activity	activity	NN	O
was	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
CA	CA	NNP	O
activity	activity	NN	O
/	/	SYM	O
mg	mg	NNP	O
of	of	IN	O
total	total	JJ	O
protein	protein	NN	O
.	.	.	O

Protein	protein	NN	O
concentration	concentration	NN	O
was	be	VBD	O
determined	determine	VBN	O
using	use	VBG	O
the	the	DT	O
Bio	Bio	NNP	O
-	-	HYPH	O
Rad	Rad	NNP	O
protein	protein	NN	O
assay	assay	NN	O
.	.	.	O

Exosomal	Exosomal	NNP	O
pH	pH	NNP	O
was	be	VBD	O
evaluated	evaluate	VBN	O
by	by	IN	O
Nanoscale	Nanoscale	NNP	O
Flow	Flow	NNP	O
Cytometry	Cytometry	NNP	O
using	use	VBG	O
the	the	DT	O
pH	ph	JJ	O
-	-	HYPH	O
sensitive	sensitive	JJ	O
fluorescent	fluorescent	NN	O
probe	probe	NN	O
BCECF	BCECF	NNP	O
AM	AM	NNP	O
2',7'-Bis--5	2',7'-Bis--5	NNS	O
-	-	:	O
-Carboxyfluorescein	-Carboxyfluorescein	VBN	O
,	,	,	O
Acetoxymethyl	Acetoxymethyl	NNP	O
Ester	Ester	NNP	O
.	.	.	O

Exosomes	Exosomes	NNP	O
purified	purify	VBN	O
from	from	IN	O
1âml	1âml	CD	O
of	of	IN	O
8	8	CD	O
PCa	PCa	NNS	O
and	and	CC	O
8	8	CD	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
samples	sample	NNS	O
were	be	VBD	O
diluted	dilute	VBN	O
in	in	IN	O
PBS	PBS	NNP	O
in	in	IN	O
a	a	DT	O
final	final	JJ	O
volume	volume	NN	O
of	of	IN	O
40âÂµl	40ââµl	CD	O
.	.	.	O

Anti	anti	JJ	O
-	-	JJ	O
human	human	JJ	O
CD81	CD81	NNP	O
allophycocyanin	allophycocyanin	NN	O
conjugated	conjugate	VBD	O
and	and	CC	O
BCECF	BCECF	NNP	O
AM	AM	NNP	O
were	be	VBD	O
added	add	VBN	O
to	to	IN	O
the	the	DT	O
exosome	exosome	JJ	O
preparation	preparation	NN	O
at	at	IN	O
optimal	optimal	JJ	O
pre	pre	JJ	O
-	-	JJ	O
titered	titere	VBN	O
concentrations	concentration	NNS	O
and	and	CC	O
left	leave	VBD	O
for	for	IN	O
20âmin	20âmin	NN	O
at	at	IN	O
RT	RT	NNP	O
.	.	.	O

Anti	Anti	NNP	O
IgG2a	IgG2a	NNP	O
APC	APC	NNP	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
isotype	isotype	NN	O
control.500âÂµl	control.500âÂµl	NNP	O
of	of	IN	O
PBS	PBS	NNP	O
were	be	VBD	O
added	add	VBN	O
to	to	IN	O
samples	sample	NNS	O
before	before	IN	O
the	the	DT	O
acquisition	acquisition	NN	O
on	on	IN	O
the	the	DT	O
CytoFLEX	CytoFLEX	NNP	O
flow	flow	NN	O
cytometer	cytometer	NN	O
.	.	.	O

The	the	DT	O
cytometer	cytometer	NN	O
was	be	VBD	O
calibrated	calibrate	VBN	O
using	use	VBG	O
a	a	DT	O
mixture	mixture	NN	O
of	of	IN	O
non	non	JJ	O
-	-	JJ	O
fluorescent	fluorescent	JJ	O
silica	silica	NN	O
beads	bead	NNS	O
and	and	CC	O
fluorescent	fluorescent	NN	O
latex	latex	NN	O
beads	bead	NNS	O
with	with	IN	O
sizes	size	NNS	O
ranging	range	VBG	O
from	from	IN	O
110ânm	110ânm	CD	O
to	to	IN	O
1300ânm	1300ânm	CD	O
.	.	.	O

This	this	DT	O
calibration	calibration	NN	O
step	step	NN	O
enables	enable	VBZ	O
the	the	DT	O
determination	determination	NN	O
of	of	IN	O
the	the	DT	O
sensitivity	sensitivity	NN	O
and	and	CC	O
resolution	resolution	NN	O
of	of	IN	O
the	the	DT	O
flow	flow	NN	O
cytometer	cytometer	NN	O
and	and	CC	O
the	the	DT	O
size	size	NN	O
of	of	IN	O
extracellular	extracellular	JJ	O
vesicles	vesicle	NNS	O
.	.	.	O

CD81	CD81	NNP	O
was	be	VBD	O
labelled	label	VBN	O
in	in	IN	O
allophycocyanin	allophycocyanin	NNP	O
that	that	WDT	O
absorbs	absorb	VBZ	O
and	and	CC	O
emits	emit	VBZ	O
red	red	JJ	O
light	light	NN	O
650	650	CD	O
and	and	CC	O
660ânm	660ânm	CD	O
max	max	NNP	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

BCECF	BCECF	NNP	O
,	,	,	O
which	which	WDT	O
emits	emit	VBZ	O
fluorescence	fluorescence	NN	O
once	once	IN	O
it	-PRON-	PRP	O
enters	enter	VBZ	O
into	into	IN	O
the	the	DT	O
acidic	acidic	JJ	O
milieu	milieu	NN	O
,	,	,	O
absorbs	absorb	VBZ	O
and	and	CC	O
emits	emit	VBZ	O
green	green	JJ	O
light	light	NN	O
488	488	CD	O
and	and	CC	O
525/640ânm	525/640ânm	NNP	O
.	.	.	O

All	all	DT	O
samples	sample	NNS	O
were	be	VBD	O
acquired	acquire	VBN	O
at	at	IN	O
low	low	JJ	O
flow	flow	NN	O
rate	rate	NN	O
for	for	IN	O
the	the	DT	O
same	same	JJ	O
amount	amount	NN	O
of	of	IN	O
time	time	NN	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
obtain	obtain	VB	O
an	an	DT	O
estimate	estimate	NN	O
of	of	IN	O
absolute	absolute	JJ	O
counts	count	NNS	O
of	of	IN	O
exosomes	exosome	NNS	O
comparable	comparable	JJ	O
between	between	IN	O
various	various	JJ	O
samples	sample	NNS	O
.	.	.	O

The	the	DT	O
analysis	analysis	NN	O
of	of	IN	O
the	the	DT	O
data	datum	NNS	O
was	be	VBD	O
performed	perform	VBN	O
with	with	IN	O
FlowJo	flowjo	DT	O
software	software	NN	B
.	.	.	O

Human	human	JJ	O
prostate	prostate	NN	O
carcinoma	carcinoma	NN	O
cell	cell	NN	O
line	line	NN	O
is	be	VBZ	O
derived	derive	VBN	O
from	from	IN	O
a	a	DT	O
metastatic	metastatic	JJ	O
site	site	NN	O
of	of	IN	O
a	a	DT	O
50-year	50-year	CD	O
-	-	HYPH	O
old	old	JJ	O
Caucasian	caucasian	JJ	O
male	male	NN	O
with	with	IN	O
confirmed	confirmed	JJ	O
diagnosis	diagnosis	NN	O
of	of	IN	O
metastatic	metastatic	JJ	O
prostate	prostate	NN	O
carcinoma	carcinoma	NN	O
.	.	.	O

Tumour	tumour	NN	O
cells	cell	NNS	O
were	be	VBD	O
negative	negative	JJ	O
for	for	IN	O
Mycoplasma	Mycoplasma	NNP	O
contamination	contamination	NN	O
as	as	RB	O
routinely	routinely	RB	O
tested	test	VBN	O
by	by	IN	O
PCR	PCR	NNP	O
VenorÂ	VenorÂ	NNP	O
®	®	NNPS	O
GeM	GeM	NNS	O
,	,	,	O
Minerva	Minerva	NNP	O
Biolabs	Biolabs	NNP	O
,	,	,	O
Germany	Germany	NNP	O
.	.	.	O

The	the	DT	O
cells	cell	NNS	O
were	be	VBD	O
maintained	maintain	VBN	O
in	in	IN	O
RPMI	RPMI	NNP	O
1640	1640	CD	O
without	without	IN	O
sodium	sodium	NN	O
bicarbonate	bicarbonate	JJ	O
culture	culture	NN	O
medium	medium	NN	O
at	at	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
supplemented	supplement	VBN	O
with	with	IN	O
antibiotics	antibiotic	NNS	O
and	and	CC	O
10	10	CD	O
%	%	NN	O
foetal	foetal	JJ	O
calf	calf	NN	O
serum	serum	NN	O
,	,	,	O
at	at	IN	O
37âÂ	37âÂ	NNP	O
°	°	,	O
C	C	NNP	O
in	in	IN	O
humidified	humidified	JJ	O
5	5	CD	O
%	%	NN	O
CO2	CO2	NNP	O
.	.	.	O

The	the	DT	O
acid	acid	JJ	O
cell	cell	NN	O
culture	culture	NN	O
medium	medium	NN	O
was	be	VBD	O
obtained	obtain	VBN	O
by	by	IN	O
the	the	DT	O
addition	addition	NN	O
of	of	IN	O
1âM	1âm	CD	O
HCl	HCl	NNP	O
solution	solution	NN	O
.	.	.	O

The	the	DT	O
pH	pH	NNP	O
was	be	VBD	O
measured	measure	VBN	O
with	with	IN	O
a	a	DT	O
pH	pH	NNP	O
123	123	CD	O
Microprocessor	Microprocessor	NNP	O
pH	pH	NNP	O
Metre	Metre	NNP	O
.	.	.	O

LNCaP	lncap	NN	O
cells	cell	NNS	O
were	be	VBD	O
slowly	slowly	RB	O
adjusted	adjust	VBN	O
to	to	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
for	for	IN	O
a	a	DT	O
sufficient	sufficient	JJ	O
time	time	NN	O
starting	start	VBG	O
from	from	IN	O
unbuffered	unbuffered	JJ	O
conditions	condition	NNS	O
,	,	,	O
allowing	allow	VBG	O
tumour	tumour	NN	O
cells	cell	NNS	O
to	to	TO	O
acidify	acidify	VB	O
the	the	DT	O
microenvironment	microenvironment	NN	O
themselves	-PRON-	PRP	O
.	.	.	O

After	after	IN	O
five	five	CD	O
days	day	NNS	O
in	in	IN	O
unbuffered	unbuffered	JJ	O
medium	medium	NN	O
,	,	,	O
measured	measure	VBN	O
pH	pH	NNP	O
of	of	IN	O
the	the	DT	O
culture	culture	NN	O
was	be	VBD	O
6.5	6.5	CD	O
.	.	.	O

Thus	thus	RB	O
,	,	,	O
we	-PRON-	PRP	O
progressively	progressively	RB	O
conditioned	condition	VBD	O
the	the	DT	O
pH	pH	NNP	O
of	of	IN	O
the	the	DT	O
cultures	culture	NNS	O
starting	start	VBG	O
from	from	IN	O
7.4	7.4	CD	O
until	until	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
in	in	IN	O
a	a	DT	O
time	time	NN	O
ranging	range	VBG	O
from	from	IN	O
three	three	CD	O
to	to	TO	O
four	four	CD	O
weeks	week	NNS	O
,	,	,	O
allowing	allow	VBG	O
the	the	DT	O
cells	cell	NNS	O
to	to	TO	O
not	not	RB	O
be	be	VB	O
exposed	expose	VBN	O
to	to	IN	O
short	short	JJ	O
-	-	HYPH	O
term	term	NN	O
pH	pH	NNP	O
stress	stress	NN	B
.	.	.	O

About	about	RB	O
1	1	CD	O
x	x	SYM	O
105	105	CD	O
cells	cell	NNS	O
/	/	SYM	O
well	well	RB	O
of	of	IN	O
LNCaP	lncap	NN	O
cells	cell	NNS	O
cultured	culture	VBN	O
at	at	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
were	be	VBD	O
seeded	seed	VBN	O
on	on	IN	O
coverslips	coverslip	NNS	O
in	in	IN	O
24-well	24-well	CD	O
plate	plate	NN	O
.	.	.	O

After	after	IN	O
24âh	24âh	CD	O
,	,	,	O
cells	cell	NNS	O
were	be	VBD	O
stained	stain	VBN	O
with	with	IN	O
BCECF	BCECF	NNP	O
AM	AM	NNP	O
10âÂµM	10ââµm	CD	O
for	for	IN	O
30âmin	30âmin	NN	O
at	at	IN	O
37âÂ	37âÂ	NNP	O
°	°	,	O
C	C	NNP	O
.	.	.	O

After	after	IN	O
being	be	VBG	O
fixed	fix	VBN	O
in	in	IN	O
4	4	CD	O
%	%	NN	O
paraformaledehyde	paraformaledehyde	NN	O
,	,	,	O
cells	cell	NNS	O
were	be	VBD	O
blocked	block	VBN	O
for	for	IN	O
1âh	1âh	CD	O
at	at	IN	O
RT	RT	NNP	O
in	in	IN	O
PBS	PBS	NNP	O
with	with	IN	O
1	1	CD	O
%	%	NN	O
BSA	BSA	NNP	O
and	and	CC	O
labelled	label	VBD	O
with	with	IN	O
CD9-PE	CD9-PE	NNP	O
mouse	mouse	NN	O
monoclonal	monoclonal	NN	O
antibody	antibody	NN	O
clone	clone	PRP$	O
LM	LM	NNP	O
-	-	HYPH	O
L13	L13	NNP	O
,	,	,	O
BD	BD	NNP	O
Biosciences	Biosciences	NNP	O
,	,	,	O
USA	USA	NNP	O
for	for	IN	O
1âh	1âh	CD	O
at	at	IN	O
RT	RT	NNP	O
;	;	:	O
then	then	RB	O
cells	cell	NNS	O
were	be	VBD	O
incubated	incubate	VBN	O
with	with	IN	O
M75	M75	NNP	O
mouse	mouse	NN	O
monoclonal	monoclonal	JJ	O
antibody	antibody	NN	B
for	for	IN	O
1âh	1âh	CD	O
at	at	IN	O
RT	RT	NNP	O
,	,	,	O
following	follow	VBG	O
from	from	IN	O
incubation	incubation	NN	O
with	with	IN	O
anti	anti	JJ	O
-	-	JJ	O
mouse	mouse	JJ	O
Alexa	Alexa	NNP	O
FluorÂ	FluorÂ	NNP	O
®	®	:	O
647	647	CD	O
secondary	secondary	JJ	O
antibody	antibody	NN	O
.	.	.	O

After	after	IN	O
washes	wash	NNS	O
in	in	IN	O
PBS	PBS	NNP	O
,	,	,	O
coverslips	coverslip	NNS	O
with	with	IN	O
DAPIâ+âProLong	DAPIâ+âProLong	NNP	O
were	be	VBD	O
transferred	transfer	VBN	O
on	on	IN	O
microscope	microscope	NN	O
slides	slide	NNS	O
and	and	CC	O
images	image	NNS	O
were	be	VBD	O
acquired	acquire	VBN	O
with	with	IN	O
an	an	DT	O
inverted	inverted	JJ	O
microscope	microscope	NN	O
equipped	equip	VBN	O
with	with	IN	O
a	a	DT	O
confocal	confocal	JJ	O
spectral	spectral	NN	O
imaging	imaging	NN	O
system	system	NN	O
using	use	VBG	O
a	a	DT	O
PlanApo	PlanApo	NNP	O
objective	objective	NN	O
60Ã	60ã	CD	O
oil	oil	NN	O
.	.	.	O

Excitation	excitation	NN	O
light	light	NN	O
was	be	VBD	O
obtained	obtain	VBN	O
by	by	IN	O
a	a	DT	O
Laser	Laser	NNP	O
Dapi	Dapi	NNP	O
408ânm	408ânm	CD	O
for	for	IN	O
DAPI	dapi	NN	O
,	,	,	O
an	an	DT	O
Argon	Argon	NNP	O
Ion	Ion	NNP	O
Laser	Laser	NNP	O
488ânm	488ânm	LS	O
for	for	IN	O
BCECF	BCECF	NNP	O
,	,	,	O
Diode	Diode	NNP	O
Laser	Laser	NNP	O
HeNe	HeNe	NNP	O
561ânm	561ânm	CD	O
for	for	IN	O
CD9-PE	CD9-PE	NNP	O
,	,	,	O
and	and	CC	O
a	a	DT	O
Red	Red	NNP	O
Diode	Diode	NNP	O
Laser	Laser	NNP	O
638ânm	638ânm	CD	O
for	for	IN	O
Alexa	Alexa	NNP	O
647	647	CD	O
.	.	.	O

Emitted	emit	VBN	O
fluorescence	fluorescence	NN	O
was	be	VBD	O
recorded	record	VBN	O
in	in	IN	O
spectral	spectral	JJ	O
â	â	NNP	O
frame	frame	NN	O
lambda	lambda	NN	O
mode	mode	NN	O
.	.	.	O

DAPI	DAPI	NNP	O
emission	emission	NN	O
was	be	VBD	O
recorded	record	VBN	O
from	from	IN	O
415	415	CD	O
to	to	IN	O
485ânm	485ânm	CD	O
,	,	,	O
BCECF	BCECF	NNP	O
emission	emission	NN	O
was	be	VBD	O
recorded	record	VBN	O
from	from	IN	O
495	495	CD	O
to	to	IN	O
550ânm	550ânm	CD	O
,	,	,	O
CD9-PE	CD9-PE	NNP	O
emission	emission	NN	O
was	be	VBD	O
recorded	record	VBN	O
from	from	IN	O
583	583	CD	O
to	to	IN	O
628ânm	628ânm	CD	O
,	,	,	O
and	and	CC	O
Alexa	Alexa	NNP	O
647	647	CD	O
from	from	IN	O
634	634	CD	O
to	to	IN	O
750ânm	750ânm	CD	O
.	.	.	O

Images	image	NNS	O
recorded	record	VBN	O
have	have	VBP	O
an	an	DT	O
optical	optical	JJ	O
thickness	thickness	NN	O
of	of	IN	O
0.20âÂµm	0.20âÂµm	NNP	O
and	and	CC	O
have	have	VBP	O
been	be	VBN	O
analysed	analyse	VBN	O
by	by	IN	O
the	the	DT	O
C1-LCSI	C1-LCSI	NNP	O
EZ	EZ	NNP	O
-	-	HYPH	O
C1	C1	NNP	O
software	software	NN	O
for	for	IN	O
spectral	spectral	JJ	O
analysis	analysis	NN	O
.	.	.	O

Signals	signal	NNS	O
from	from	IN	O
different	different	JJ	O
fluorescent	fluorescent	NN	O
probes	probe	NNS	O
were	be	VBD	O
taken	take	VBN	O
in	in	IN	O
sequential	sequential	JJ	O
scanning	scanning	NN	O
mode	mode	NN	O
,	,	,	O
several	several	JJ	O
fields	field	NNS	O
were	be	VBD	O
analysed	analyse	VBN	O
for	for	IN	O
each	each	DT	O
labelling	labelling	NN	O
condition	condition	NN	O
,	,	,	O
and	and	CC	O
representative	representative	JJ	O
results	result	NNS	O
are	be	VBP	O
shown	show	VBN	O
.	.	.	O

Results	result	NNS	O
in	in	IN	O
the	the	DT	O
text	text	NN	O
are	be	VBP	O
expressed	express	VBN	O
as	as	IN	O
meansâÂ±âstandard	meansââ±âstandard	JJ	O
error	error	NN	O
,	,	,	O
calculated	calculate	VBN	O
using	use	VBG	O
the	the	DT	O
GraphPad	GraphPad	NNP	O
Prism	Prism	NNP	O
software	software	NN	O
.	.	.	O

The	the	DT	O
statistical	statistical	JJ	O
analysis	analysis	NN	O
was	be	VBD	O
done	do	VBN	O
with	with	IN	O
an	an	DT	O
unpaired	unpaired	JJ	O
t	t	NN	O
-	-	HYPH	O
test	test	NN	O
Studentâs	studentâs	CD	O
t	t	NN	O
-	-	HYPH	O
test	test	NN	O
.	.	.	O

A	a	DT	O
series	series	NN	O
of	of	IN	O
experiments	experiment	NNS	O
aimed	aim	VBN	O
at	at	IN	O
evaluating	evaluate	VBG	O
the	the	DT	O
level	level	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
in	in	IN	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
PCa	PCa	NNP	O
and	and	CC	O
control	control	NN	O
plasma	plasma	NN	O
has	have	VBZ	O
been	be	VBN	O
performed	perform	VBN	O
.	.	.	O

Exosomes	exosome	NNS	O
isolated	isolate	VBN	O
by	by	IN	O
ultracentrifugation	ultracentrifugation	NN	O
were	be	VBD	O
characterised	characterise	VBN	O
and	and	CC	O
quantified	quantify	VBN	O
by	by	IN	O
Nanoparticle	Nanoparticle	NNP	O
Tracking	Tracking	NNP	O
Analysis	Analysis	NNP	O
and	and	CC	O
the	the	DT	O
expression	expression	NN	O
of	of	IN	O
the	the	DT	O
exosomal	exosomal	JJ	O
markers	markers	NNPS	O
Alix	Alix	NNP	O
and	and	CC	O
CD81	CD81	NNP	O
.	.	.	O

PCa	PCa	NNS	O
patients	patient	NNS	O
showed	show	VBD	O
higher	high	JJR	O
plasmatic	plasmatic	JJ	O
levels	level	NNS	O
of	of	IN	O
exosomes	exosome	NNS	O
than	than	IN	O
the	the	DT	O
controls	control	NNS	O
pâ<â.1	pâ<â.1	NNP	O
Figure	figure	NN	O
1(AâC	1(aâc	CD	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
exosomes	exosome	VBZ	O
from	from	IN	O
PCa	PCa	NNP	O
patients	patient	NNS	O
were	be	VBD	O
more	more	RBR	O
homogeneous	homogeneous	JJ	O
in	in	IN	O
size	size	NN	O
distributionin	distributionin	NN	O
respect	respect	NN	O
to	to	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
from	from	IN	O
CTR	CTR	NNP	O
Figure	Figure	NNP	O
1(AâC	1(aâc	CD	O
.	.	.	O

Thus	thus	RB	O
,	,	,	O
to	to	TO	O
eliminate	eliminate	VB	O
contaminants	contaminant	NNS	O
,	,	,	O
the	the	DT	O
Western	Western	NNP	O
Blot	Blot	NNP	O
Analysis	Analysis	NNP	O
of	of	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
by	by	IN	O
differential	differential	JJ	O
ultracentrifugation	ultracentrifugation	NN	O
and	and	CC	O
further	further	RB	O
using	use	VBG	O
30	30	CD	O
%	%	NN	O
sucrose	sucrose	JJ	O
density	density	NN	O
gradient	gradient	NNP	O
ultracentrifugation	ultracentrifugation	NNP	O
was	be	VBD	O
performed	perform	VBN	B
,	,	,	B
.	.	.	O

The	the	DT	O
resulting	result	VBG	O
fractions	fraction	NNS	O
were	be	VBD	O
blotted	blot	VBN	O
for	for	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
and	and	CC	O
exosomal	exosomal	JJ	O
markers	marker	NNS	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
showed	show	VBD	O
that	that	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
was	be	VBD	O
up	up	RB	O
-	-	HYPH	O
regulated	regulated	JJ	O
in	in	IN	O
exosomal	exosomal	JJ	O
purification	purification	NN	O
lysates	lysate	NNS	O
from	from	IN	O
PCa	PCa	NNP	O
plasma	plasma	NN	O
patients	patient	NNS	O
Figure	figure	NN	O
2	2	CD	O
as	as	IN	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
exosomal	exosomal	JJ	O
fractions	fraction	NNS	O
of	of	IN	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
Figure	Figure	NNP	O
2	2	CD	O
.	.	.	O

Figure	figure	NN	O
2	2	CD	O
also	also	RB	O
shows	show	VBZ	O
that	that	IN	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
band	band	NN	O
corresponded	correspond	VBD	O
to	to	IN	O
the	the	DT	O
typical	typical	JJ	O
exosome	exosome	JJ	O
fractions	fraction	NNS	O
as	as	IN	O
identified	identify	VBN	O
by	by	IN	O
the	the	DT	O
expression	expression	NN	O
of	of	IN	O
Alix	Alix	NNP	O
and	and	CC	O
CD81	CD81	NNP	O
in	in	IN	O
the	the	DT	O
second	second	JJ	O
and	and	CC	O
third	third	JJ	O
fractions	fraction	NNS	O
of	of	IN	O
the	the	DT	O
density	density	NN	O
gradient	gradient	NN	O
.	.	.	O

As	as	IN	O
shown	show	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
2	2	CD	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
in	in	IN	O
PCa	PCa	NNP	O
exosomes	exosome	NNS	O
is	be	VBZ	O
evidenced	evidence	VBN	O
by	by	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
two	two	CD	O
bands	band	NNS	O
58/54âkDa	58/54âkda	LS	O
.	.	.	O

The	the	DT	O
CTR	CTR	NNP	O
exosomes	exosome	NNS	O
Figure	figure	NN	O
2	2	CD	O
exclusively	exclusively	RB	O
showed	show	VBD	O
the	the	DT	O
Alix	Alix	NNP	O
and	and	CC	O
CD81	CD81	NNP	O
bands	band	NNS	O
.	.	.	O

Nanoparticle	nanoparticle	NN	O
tracking	track	VBG	O
analysis	analysis	NN	O
quantification	quantification	NN	O
of	of	IN	O
exosomes	exosome	NNS	O
released	release	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
PCa	PCa	NNP	O
patients	patient	NNS	O
and	and	CC	O
CTR	CTR	NNP	O
.	.	.	O

NTA	NTA	NNP	O
distribution	distribution	NN	O
of	of	IN	O
CTR	CTR	NNP	O
exosomes	exosome	NNS	O
.	.	.	O

NTA	nta	JJ	O
distribution	distribution	NN	O
of	of	IN	O
PCa	PCa	NNP	O
exosomes	exosome	NNS	O
.	.	.	O

Concentration	concentration	NN	O
of	of	IN	O
exosomes	exosome	NNS	O
.	.	.	O

MeanâÂ±âSE	meanââ±âse	CD	O
of	of	IN	O
plasma	plasma	NNP	O
exosomes	exosome	VBZ	O
from	from	IN	O
8	8	CD	O
CTR	CTR	NNP	O
and	and	CC	O
8	8	CD	O
PCa	PCa	NNS	O
patients	patient	NNS	O
are	be	VBP	O
shown	show	VBN	O
.	.	.	O

The	the	DT	O
p	p	NN	O
values	value	NNS	O
was	be	VBD	O
<	<	XX	O
.1	.1	XX	O
in	in	IN	O
PCa	PCa	NNP	O
plasma	plasma	NN	O
respect	respect	NN	O
to	to	IN	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
exosomes	exosome	VBZ	O
.	.	.	O

*	*	NFP	O
pâ<â.1	pâ<â.1	NNP	O
.	.	.	O

Western	western	JJ	O
blot	blot	NN	O
analysis	analysis	NN	O
of	of	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
from	from	IN	O
PCa	PCa	NNP	O
patients	patient	NNS	O
and	and	CC	O
CTR	CTR	NNP	O
after	after	IN	O
30	30	CD	O
%	%	NN	O
sucrose	sucrose	JJ	O
density	density	NN	O
gradient	gradient	NN	O
ultracentrifugation	ultracentrifugation	NN	O
for	for	IN	O
housekeeping	housekeep	VBG	O
markers	marker	NNS	O
and	and	CC	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
.	.	.	O

Protein	protein	NN	O
characterisation	characterisation	NN	O
of	of	IN	O
exosomal	exosomal	JJ	O
fractions	fraction	NNS	O
purified	purify	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
PCa	PCa	NNP	O
patients	patient	NNS	O
performed	perform	VBN	O
with	with	IN	O
anti	anti	JJ	O
-	-	NNP	O
Alix	alix	JJ	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
CD81	CD81	NNP	O
and	and	CC	O
M75	M75	NNP	O
.	.	.	O

Protein	protein	NN	O
characterisation	characterisation	NN	O
of	of	IN	O
exosomal	exosomal	JJ	O
fractions	fraction	NNS	O
purified	purify	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
CTR	CTR	NNP	O
performed	perform	VBD	O
with	with	IN	O
anti	anti	JJ	O
-	-	NNP	O
Alix	alix	JJ	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
CD81	CD81	NNP	O
and	and	CC	O
M75	M75	NNP	O
.	.	.	O

To	to	TO	O
support	support	VB	O
this	this	DT	O
set	set	NN	O
of	of	IN	O
results	result	NNS	O
,	,	,	O
we	-PRON-	PRP	O
exploited	exploit	VBD	O
an	an	DT	O
immunocapture	immunocapture	NN	O
-	-	HYPH	O
based	base	VBN	O
ELISA	ELISA	NNP	O
assay	assay	NN	O
to	to	TO	O
quantify	quantify	VB	O
and	and	CC	O
characterise	characterise	VB	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
levels	level	NNS	O
in	in	IN	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
1âml	1âml	CD	O
of	of	IN	O
either	either	DT	O
PCa	PCa	NNS	O
or	or	CC	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
,	,	,	O
by	by	IN	O
seeding	seed	VBG	O
the	the	DT	O
same	same	JJ	O
amount	amount	NN	O
of	of	IN	O
exosomes	exosome	NNS	O
preparations	preparation	NNS	O
50âÂµl	50ââµl	CD	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
positive	positive	JJ	O
exosomes	exosome	NNS	O
were	be	VBD	O
25-fold	25-fold	CD	O
higher	high	JJR	O
in	in	IN	O
plasma	plasma	NN	O
of	of	IN	O
PCa	PCa	NNP	O
patients	patient	NNS	O
558âÂ±â90	558ââ±â90	CD	O
than	than	IN	O
in	in	IN	O
CTR	CTR	NNP	O
22âÂ±â2	22ââ±â2	CD	O
,	,	,	O
pâ<â.0001	pâ<â.0001	NN	O
.	.	.	O

The	the	DT	O
plasma	plasma	NN	O
deprived	deprive	VBN	O
of	of	IN	O
exosomes	exosome	NNS	O
was	be	VBD	O
entirely	entirely	RB	O
negative	negative	JJ	O
for	for	IN	O
both	both	DT	O
markers	marker	NNS	O
.	.	.	O

Detection	detection	NN	O
,	,	,	O
quantification	quantification	NN	O
and	and	CC	O
characterisation	characterisation	NN	O
of	of	IN	O
CAIX+/CD81	caix+/cd81	CD	O
+	+	SYM	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
PCa	PCa	NNP	O
and	and	CC	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
by	by	IN	O
ELISA	ELISA	NNP	O
test	test	NN	O
.	.	.	O

ELISA	ELISA	NNP	O
analysis	analysis	NN	O
of	of	IN	O
CAIX	CAIX	NNP	O
and	and	CC	O
CD81	CD81	NNP	O
expression	expression	NN	O
in	in	IN	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
8	8	CD	O
PCa	PCa	NNS	O
patients	patient	NNS	O
and	and	CC	O
8	8	CD	O
CTR	CTR	NNP	O
1âml	1âml	CD	O
for	for	IN	O
each	each	DT	O
sample	sample	NN	O
.	.	.	O

Rabbit	rabbit	NN	O
polyclonal	polyclonal	JJ	O
anti	anti	JJ	O
-	-	JJ	O
CD81	cd81	JJ	O
antibody	antibody	NN	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
the	the	DT	O
capture	capture	NN	O
of	of	IN	O
exosomes	exosome	NNS	O
on	on	IN	O
the	the	DT	O
plate	plate	NN	O
.	.	.	O

Expression	expression	NN	O
levels	level	NNS	O
of	of	IN	O
exosomal	exosomal	JJ	O
CAIX	CAIX	NNP	O
were	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
meansâÂ±âES	meansâÂ±âES	NNP	O
.	.	.	O

The	the	DT	O
p	p	NN	O
values	value	NNS	O
was	be	VBD	O
<	<	XX	O
.0001	.0001	.	O
in	in	IN	O
PCa	PCa	NNP	O
plasma	plasma	NNP	O
exosomes	exosome	VBZ	O
respect	respect	NN	O
to	to	IN	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
exosomes	exosome	VBZ	O
.	.	.	O

*	*	NFP	O
*	*	NFP	O
*	*	NFP	O
*	*	NFP	O
pâ<â.0001	pâ<â.0001	UH	O
.	.	.	O

The	the	DT	O
CA	CA	NNP	O
IX	ix	NN	O
-	-	HYPH	O
activity	activity	NN	O
of	of	IN	O
exosomes	exosome	NNS	O
isolated	isolate	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
PCa	PCa	NNP	O
and	and	CC	O
CTR	CTR	NNP	O
has	have	VBZ	O
been	be	VBN	O
analysed	analyse	VBN	O
using	use	VBG	O
the	the	DT	O
colorimetric	colorimetric	JJ	O
CA	CA	NNP	O
assay	assay	NN	O
as	as	IN	O
described	describe	VBN	O
in	in	IN	O
the	the	DT	O
âMaterials	âMaterials	NNPS	O
and	and	CC	O
Methodsâ	methodsâ	NN	O
section	section	NN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
CA	CA	NNP	O
-	-	HYPH	O
activity	activity	NN	O
/	/	SYM	O
mg	mg	NNP	O
protein	protein	NN	O
found	find	VBD	O
in	in	IN	O
exosomes	exosome	NNS	O
isolated	isolate	VBN	O
from	from	IN	O
PCa	PCa	NNP	O
plasma	plasma	NNP	O
2.9âÂ±â0.4	2.9ââ±â0.4	CD	O
was	be	VBD	O
2.4-fold	2.4-fold	CD	O
higher	high	JJR	O
as	as	IN	O
compared	compare	VBN	O
to	to	IN	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
1.2âÂ±â0.2	1.2ââ±â0.2	CD	O
pâ<â.0001	pâ<â.0001	NN	O
;	;	:	O
thus	thus	RB	O
supporting	support	VBG	O
that	that	IN	O
the	the	DT	O
increased	increase	VBN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
in	in	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
of	of	IN	O
PCa	PCa	NNP	O
patients	patient	NNS	O
was	be	VBD	O
consistent	consistent	JJ	O
with	with	IN	O
a	a	DT	O
real	real	JJ	O
enzyme	enzyme	NNS	O
activity	activity	NN	O
up	up	RB	O
-	-	HYPH	O
regulated	regulated	JJ	O
in	in	IN	O
PCa	PCa	NNP	O
plasma	plasma	NN	O
exosomes	exosome	VBZ	O
.	.	.	O

This	this	DT	O
result	result	NN	O
is	be	VBZ	O
,	,	,	O
of	of	IN	O
course	course	NN	O
,	,	,	O
of	of	IN	O
paramount	paramount	JJ	O
importance	importance	NN	O
since	since	IN	O
circulating	circulate	VBG	O
exosomes	exosome	NNS	O
may	may	MD	O
export	export	VB	O
to	to	IN	O
other	other	JJ	O
tissues	tissue	NNS	O
a	a	DT	O
function	function	NN	O
that	that	WDT	O
appears	appear	VBZ	O
to	to	TO	O
be	be	VB	O
associated	associate	VBN	O
with	with	IN	O
malignancy	malignancy	NN	O
.	.	.	O

Analysis	analysis	NN	O
of	of	IN	O
CAIX	CAIX	NNP	O
enzymatic	enzymatic	JJ	O
activity	activity	NN	O
of	of	IN	O
plasma	plasma	NN	O
exosomes	exosome	VBZ	O
from	from	IN	O
PCa	PCa	NNP	O
and	and	CC	O
CTR	CTR	NNP	O
.	.	.	O

CA	CA	NNP	O
IX	IX	NNP	O
activity	activity	NN	O
is	be	VBZ	O
shown	show	VBN	O
for	for	IN	O
plasma	plasma	NN	O
exosomes	exosome	VBZ	O
purified	purify	VBN	O
from	from	IN	O
8	8	CD	O
PCa	PCa	NNS	O
patients	patient	NNS	O
and	and	CC	O
8	8	CD	O
CTR	CTR	NNP	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
were	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
meansâÂ±âSD	meansâÂ±âSD	NNP	O
of	of	IN	O
CA	CA	NNP	O
-	-	HYPH	O
activity	activity	NNP	O
/	/	SYM	O
mg	mg	NNP	O
protein	protein	NN	O
found	find	VBD	O
in	in	IN	O
exosomes	exosome	NNS	O
.	.	.	O

The	the	DT	O
p	p	NN	O
values	value	NNS	O
was	be	VBD	O
<	<	XX	O
.0001	.0001	.	O
in	in	IN	O
PCa	PCa	NNP	O
plasma	plasma	NNP	O
exosomes	exosome	VBZ	O
respect	respect	NN	O
to	to	IN	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
exosomes	exosome	VBZ	O
.	.	.	O

*	*	NFP	O
*	*	NFP	O
*	*	NFP	O
*	*	NFP	O
pâ<â.0001	pâ<â.0001	UH	O
.	.	.	O

Recently	recently	RB	O
,	,	,	O
our	-PRON-	PRP$	O
groups	group	NNS	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
tumour	tumour	NN	O
acidic	acidic	JJ	O
microenvironment	microenvironment	NN	O
markedly	markedly	RB	O
increases	increase	VBZ	O
the	the	DT	O
number	number	NN	O
of	of	IN	O
exosomes	exosome	NNS	O
,	,	,	O
also	also	RB	O
those	those	DT	O
expressing	express	VBG	O
CA	CA	NNP	O
IX	IX	NNP	B
,	,	,	B
,	,	,	B
.	.	.	O

However	however	RB	O
,	,	,	O
never	never	RB	O
the	the	DT	O
acidity	acidity	NN	O
of	of	IN	O
the	the	DT	O
tumour	tumour	NN	O
microenvironment	microenvironment	NN	O
has	have	VBZ	O
been	be	VBN	O
associated	associate	VBN	O
with	with	IN	O
the	the	DT	O
intraluminal	intraluminal	JJ	O
acidification	acidification	NN	O
of	of	IN	O
the	the	DT	O
exosome	exosome	NN	O
released	release	VBN	O
by	by	IN	O
cancer	cancer	NN	O
cells	cell	NNS	O
.	.	.	O

Thus	thus	RB	O
,	,	,	O
in	in	IN	O
this	this	DT	O
set	set	NN	O
of	of	IN	O
experiments	experiment	NNS	O
we	-PRON-	PRP	O
studied	study	VBD	O
the	the	DT	O
intraluminal	intraluminal	JJ	O
pH	pH	NNP	O
in	in	IN	O
plasmatic	plasmatic	JJ	O
exosome	exosome	JJ	O
preparations	preparation	NNS	O
from	from	IN	O
either	either	DT	O
PCa	PCa	NNS	O
or	or	CC	O
CTR	CTR	NNP	O
.	.	.	O

Plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
PCa	PCa	NNP	O
and	and	CC	O
CTR	CTR	NNP	O
samples	sample	NNS	O
were	be	VBD	O
analysed	analyse	VBN	O
using	use	VBG	O
Nanoscale	Nanoscale	NNP	O
Flow	Flow	NNP	O
Cytometry	Cytometry	NNP	O
for	for	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
typical	typical	JJ	O
exosomal	exosomal	JJ	O
CD81	CD81	NNP	O
marker	marker	NN	O
,	,	,	O
and	and	CC	O
the	the	DT	O
expression	expression	NN	O
of	of	IN	O
the	the	DT	O
fluorescent	fluorescent	JJ	O
indicator	indicator	NN	O
for	for	IN	O
cytosolic	cytosolic	JJ	O
pH	pH	NNP	O
,	,	,	O
BCECF	BCECF	NNP	O
.	.	.	O

Double	double	JJ	O
-	-	HYPH	O
positive	positive	JJ	O
events	event	NNS	O
were	be	VBD	O
counted	count	VBN	O
and	and	CC	O
analysed	analyse	VBN	O
by	by	IN	O
size	size	NN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
number	number	NN	O
of	of	IN	O
double	double	JJ	O
-	-	HYPH	O
positive	positive	JJ	O
exosomes	exosome	NNS	O
smaller	small	JJR	O
than	than	IN	O
180ânm	180ânm	CD	O
was	be	VBD	O
higher	high	JJR	O
in	in	IN	O
PCa	PCa	NNP	O
patients	patient	NNS	O
as	as	IN	O
compared	compare	VBN	O
to	to	IN	O
CTR	CTR	NNP	O
.	.	.	O

Figure	figure	NN	O
5	5	CD	O
shows	show	VBZ	O
the	the	DT	O
absolute	absolute	JJ	O
average	average	JJ	O
number	number	NN	O
of	of	IN	O
CD81+/BCECFâ+âexosomes	CD81+/BCECFâ+âexosomes	NNP	O
sizes	size	NNS	O
less	less	JJR	O
than	than	IN	O
180ânm	180ânm	CD	O
obtained	obtain	VBN	O
from	from	IN	O
either	either	DT	O
PCa	PCa	NNS	O
or	or	CC	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
.	.	.	O

In	in	IN	O
particular	particular	JJ	O
,	,	,	O
the	the	DT	O
amount	amount	NN	O
of	of	IN	O
acidic	acidic	JJ	O
exosome	exosome	NN	O
was	be	VBD	O
2-folds	2-folds	CD	O
higher	high	JJR	O
in	in	IN	O
PCa	PCa	NNP	O
plasma	plasma	NN	O
10	10	CD	O
510âÂ±â2551	510ââ±â2551	CD	O
as	as	IN	O
compared	compare	VBN	O
to	to	IN	O
CTR	CTR	NNP	O
plasma	plasma	NN	O
6184âÂ±â1015	6184ââ±â1015	CD	O
pâ<â.1	pâ<â.1	NNP	O
.	.	.	O

These	these	DT	O
results	result	NNS	O
evidenced	evidence	VBN	O
for	for	IN	O
the	the	DT	O
first	first	JJ	O
time	time	NN	O
that	that	IN	O
an	an	DT	O
intraluminal	intraluminal	JJ	O
acidic	acidic	NN	O
pH	pH	NNP	O
characterised	characterise	VBD	O
the	the	DT	O
exosomes	exosome	NNS	O
of	of	IN	O
PCa	PCa	NNP	O
plasma	plasma	NN	O
patients	patient	NNS	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
consistent	consistent	JJ	O
with	with	IN	O
the	the	DT	O
higher	high	JJR	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
of	of	IN	O
a	a	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
,	,	,	O
a	a	DT	O
protein	protein	NN	O
associated	associate	VBN	O
with	with	IN	O
both	both	DT	O
acidity	acidity	NN	O
and	and	CC	O
hypoxia	hypoxia	NN	O
.	.	.	O

The	the	DT	O
statistical	statistical	JJ	O
analysis	analysis	NN	O
was	be	VBD	O
performed	perform	VBN	O
using	use	VBG	O
the	the	DT	O
unpaired	unpaired	JJ	O
t	t	NN	O
-	-	HYPH	O
test	test	NN	O
with	with	IN	O
the	the	DT	O
GraphPad	GraphPad	NNP	O
Prism	Prism	NNP	O
6	6	CD	O
software	software	NN	O
.	.	.	O

Nanoscale	nanoscale	JJ	O
flow	flow	NN	O
cytometry	cytometry	NN	O
of	of	IN	O
plasma	plasma	NN	O
exosomes	exosome	VBZ	O
in	in	IN	O
PCa	PCa	NNP	O
and	and	CC	O
CTR	CTR	NNP	O
for	for	IN	O
intraluminal	intraluminal	JJ	O
pH	ph	NN	O
evaluation	evaluation	NN	O
.	.	.	O

The	the	DT	O
cytometer	cytometer	NN	O
was	be	VBD	O
calibrated	calibrate	VBN	O
using	use	VBG	O
a	a	DT	O
mixture	mixture	NN	O
of	of	IN	O
non	non	JJ	O
-	-	JJ	O
fluorescent	fluorescent	JJ	O
silica	silica	NN	O
beads	bead	NNS	O
and	and	CC	O
fluorescent	fluorescent	NN	O
latex	latex	NN	O
beads	bead	NNS	O
with	with	IN	O
sizes	size	NNS	O
from	from	IN	O
110ânm	110ânm	CD	O
to	to	IN	O
1300ânm	1300ânm	CD	O
.	.	.	O

The	the	DT	O
exosome	exosome	JJ	O
preparation	preparation	NN	O
derived	derive	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
8	8	CD	O
PCa	PCa	NNS	O
patients	patient	NNS	O
and	and	CC	O
8	8	CD	O
CTR	CTR	NNP	O
were	be	VBD	O
stained	stain	VBN	O
20âmin	20âmin	NN	O
at	at	IN	O
RT	RT	NNP	O
with	with	IN	O
anti	anti	JJ	O
-	-	JJ	O
CD81	cd81	JJ	O
antibody	antibody	NN	O
and	and	CC	O
BCECF	BCECF	NNP	O
AM	AM	NNP	O
10âÂµM	10ââµm	CD	O
and	and	CC	O
analysed	analyse	VBN	O
using	use	VBG	O
flow	flow	NN	O
cytometry	cytometry	NN	O
.	.	.	O

The	the	DT	O
double	double	JJ	O
-	-	HYPH	O
positive	positive	JJ	O
events	event	NNS	O
were	be	VBD	O
then	then	RB	O
analysed	analyse	VBN	O
for	for	IN	O
their	-PRON-	PRP$	O
size	size	NN	O
,	,	,	O
based	base	VBN	O
on	on	IN	O
the	the	DT	O
calibration	calibration	NN	O
with	with	IN	O
beads	bead	NNS	O
.	.	.	O

Cumulative	cumulative	JJ	O
data	datum	NNS	O
are	be	VBP	O
shown	show	VBN	O
of	of	IN	O
the	the	DT	O
absolute	absolute	JJ	O
number	number	NN	O
of	of	IN	O
CD81+/BCECFâ+âexosomes	CD81+/BCECFâ+âexosomes	NNP	O
of	of	IN	O
size	size	NN	O
less	less	JJR	O
than	than	IN	O
180ânm	180ânm	CD	O
recovered	recover	VBN	O
from	from	IN	O
the	the	DT	O
plasma	plasma	NN	O
samples	sample	NNS	O
.	.	.	O

Data	datum	NNS	O
are	be	VBP	O
expressed	express	VBN	O
as	as	IN	O
meansâÂ±âSE	meansâÂ±âSE	NNP	O
.	.	.	O

The	the	DT	O
p	p	NN	O
values	value	NNS	O
was	be	VBD	O
<	<	XX	O
.1	.1	XX	O
in	in	IN	O
PCa	PCa	NNP	O
plasma	plasma	NNP	O
exosomes	exosome	VBZ	O
compared	compare	VBN	O
to	to	IN	O
CTR	CTR	NNP	O
.	.	.	O

*	*	NFP	O
pâ<â.1	pâ<â.1	NNP	O
.	.	.	O

The	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
was	be	VBD	O
determined	determine	VBN	O
and	and	CC	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
level	level	NN	O
of	of	IN	O
intracellular	intracellular	JJ	O
acidity	acidity	NN	O
in	in	IN	O
a	a	DT	O
human	human	JJ	O
prostate	prostate	NN	O
cancer	cancer	NN	O
cell	cell	NN	O
line	line	NN	O
cultured	culture	VBN	O
at	at	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
.	.	.	O

Intracellular	intracellular	JJ	O
acidity	acidity	NN	O
was	be	VBD	O
analysed	analyse	VBN	O
by	by	IN	O
Confocal	Confocal	NNP	O
Microscopy	Microscopy	NNP	O
using	use	VBG	O
BCECF	BCECF	NNP	O
,	,	,	O
the	the	DT	O
fluorescent	fluorescent	NN	O
tracer	tracer	NN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
showed	show	VBD	O
a	a	DT	O
massive	massive	JJ	O
cytoplasmic	cytoplasmic	JJ	O
distribution	distribution	NN	O
of	of	IN	O
BCECF	BCECF	NNP	O
Figure	Figure	NNP	O
6	6	CD	O
in	in	IN	O
LNCaP	lncap	NN	O
cultured	culture	VBN	O
in	in	IN	O
acidic	acidic	JJ	O
conditions	condition	NNS	O
.	.	.	O

This	this	DT	O
is	be	VBZ	O
due	due	JJ	O
to	to	IN	O
the	the	DT	O
intake	intake	NN	O
of	of	IN	O
BCECF	BCECF	NNP	O
into	into	IN	O
the	the	DT	O
cells	cell	NNS	O
triggered	trigger	VBN	O
by	by	IN	O
the	the	DT	O
low	low	JJ	O
intracellular	intracellular	JJ	O
pH.	pH.	NNP	O
The	the	DT	O
BCECF	BCECF	NNP	O
staining	staining	NN	O
was	be	VBD	O
consistent	consistent	JJ	O
with	with	IN	O
the	the	DT	O
CD9	CD9	NNP	O
staining	staining	NN	O
,	,	,	O
predominantly	predominantly	RB	O
at	at	IN	O
the	the	DT	O
plasma	plasma	NN	O
membrane	membrane	NN	O
level	level	NN	O
,	,	,	O
while	while	IN	O
detectable	detectable	JJ	O
at	at	IN	O
the	the	DT	O
cytoplasm	cytoplasm	NN	O
level	level	NN	O
as	as	RB	O
well	well	RB	O
Figure	figure	NN	O
6	6	CD	O
.	.	.	O

Interestingly	interestingly	RB	O
,	,	,	O
we	-PRON-	PRP	O
showed	show	VBD	O
a	a	DT	O
similar	similar	JJ	O
distribution	distribution	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
mainly	mainly	RB	O
localised	localise	VBN	O
at	at	IN	O
the	the	DT	O
plasma	plasma	NN	O
membrane	membrane	NN	O
,	,	,	O
also	also	RB	O
into	into	IN	O
the	the	DT	O
cytoplasm	cytoplasm	NN	O
,	,	,	O
but	but	CC	O
associated	associate	VBN	O
with	with	IN	O
the	the	DT	O
nuclear	nuclear	JJ	O
membrane	membrane	NN	O
as	as	RB	O
well	well	RB	O
Figure	figure	NN	O
6	6	CD	O
.	.	.	O

Figure	figure	NN	O
6shows	6shows	CD	O
the	the	DT	O
merged	merged	JJ	O
distribution	distribution	NN	O
within	within	IN	O
the	the	DT	O
LNCaP	lncap	NN	O
cells	cell	NNS	O
of	of	IN	O
the	the	DT	O
four	four	CD	O
fluorescent	fluorescent	NN	O
dyes	dye	NNS	O
used	use	VBN	O
to	to	TO	O
identify	identify	VB	O
the	the	DT	O
nucleus	nucleus	NN	O
,	,	,	O
BCECF	BCECF	NNP	O
,	,	,	O
CD9	CD9	NNP	O
and	and	CC	O
CA	CA	NNP	O
IX	IX	NNP	O
.	.	.	O

CD9	CD9	NNP	O
/	/	SYM	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
co	co	JJ	O
-	-	VBN	O
localised	localised	JJ	O
within	within	IN	O
low	low	JJ	O
pH	pH	NNP	O
cultured	cultured	JJ	O
cancer	cancer	NN	O
cells	cell	NNS	O
.	.	.	O

The	the	DT	O
staining	stain	VBG	O
partially	partially	RB	O
overlaps	overlap	VBZ	O
the	the	DT	O
BCECF	BCECF	NNP	O
fluorescence	fluorescence	NN	O
suggesting	suggest	VBG	O
that	that	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
expressed	express	VBN	O
during	during	IN	O
exosome	exosome	JJ	O
release	release	NN	O
in	in	IN	O
acidic	acidic	JJ	O
conditions	condition	NNS	O
and	and	CC	O
that	that	IN	O
these	these	DT	O
exosomes	exosome	NNS	O
are	be	VBP	O
acidic	acidic	JJ	O
as	as	RB	O
well	well	RB	O
.	.	.	O

Confocal	confocal	JJ	O
microscopy	microscopy	JJ	O
analysis	analysis	NN	O
of	of	IN	O
BCECF	BCECF	NNP	O
and	and	CC	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
in	in	IN	O
LNCaP	lncap	NN	O
cell	cell	NN	O
line	line	NN	O
cultured	culture	VBN	O
at	at	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
.	.	.	O

Isotype	Isotype	NNP	O
control	control	NN	O
cell	cell	NN	O
.	.	.	O

LNCaP	LNCaP	NNP	O
cell	cell	NN	O
labelled	label	VBN	O
with	with	IN	O
BCECF	BCECF	NNP	O
.	.	.	O

LNCaP	LNCaP	NNP	O
cell	cell	NN	O
labelled	label	VBN	O
with	with	IN	O
CD9	CD9	NNP	O
monoclonal	monoclonal	JJ	O
antibody	antibody	NN	O
.	.	.	O

LNCaP	LNCaP	NNP	O
cell	cell	NN	O
incubated	incubate	VBD	O
with	with	IN	O
M75	M75	NNP	O
and	and	CC	O
then	then	RB	O
with	with	IN	O
Alexa	Alexa	NNP	O
FluorÂ	FluorÂ	NNP	O
®	®	:	O
647	647	CD	O
secondary	secondary	JJ	O
antibody	antibody	NN	O
for	for	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
detection	detection	NN	O
.	.	.	O

Merged	merged	JJ	O
image	image	NN	O
of	of	IN	O
different	different	JJ	O
signals	signal	NNS	O
on	on	IN	O
LNCaP	lncap	NN	O
cells	cell	NNS	O
:	:	:	O
BCECF	BCECF	NNP	O
,	,	,	O
CD9	CD9	NNP	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
,	,	,	O
nucleus	nucleus	NN	O
.	.	.	O

Among	among	IN	O
the	the	DT	O
phenotypes	phenotype	NNS	O
common	common	JJ	O
to	to	IN	O
virtually	virtually	RB	O
all	all	DT	O
malignant	malignant	JJ	O
tumours	tumour	NNS	O
are	be	VBP	O
hypoxia	hypoxia	NNP	O
,	,	,	O
acidity	acidity	NN	O
,	,	,	O
and	and	CC	O
low	low	JJ	O
nutrient	nutrient	NN	O
supply	supply	NN	B
and	and	CC	O
ROS	ros	NN	O
hyperproduction	hyperproduction	NN	O
,	,	,	O
as	as	RB	O
recently	recently	RB	O
described	describe	VBN	B
.	.	.	O

In	in	IN	O
particular	particular	JJ	O
,	,	,	O
acidic	acidic	JJ	O
extracellular	extracellular	NNP	O
microenvironment	microenvironment	NN	O
induces	induce	VBZ	O
a	a	DT	O
selective	selective	JJ	O
pressure	pressure	NN	O
leading	lead	VBG	O
to	to	IN	O
selection	selection	NN	O
of	of	IN	O
cancer	cancer	NN	O
cells	cell	NNS	O
armed	arm	VBN	O
to	to	TO	O
survive	survive	VB	O
in	in	IN	O
extreme	extreme	JJ	O
microenvironmental	microenvironmental	JJ	O
conditions	condition	NNS	B
.	.	.	O

Between	between	IN	O
these	these	DT	O
adaptive	adaptive	JJ	O
advantages	advantage	NNS	O
,	,	,	O
cancer	cancer	NN	O
cells	cell	NNS	O
implement	implement	VBP	O
a	a	DT	O
series	series	NN	O
of	of	IN	O
strategies	strategy	NNS	O
,	,	,	O
making	make	VBG	O
them	-PRON-	PRP	O
very	very	RB	O
similar	similar	JJ	O
to	to	IN	O
unicellular	unicellular	JJ	O
organisms	organism	NNS	B
,	,	,	B
.	.	.	O

However	however	RB	O
,	,	,	O
to	to	TO	O
prevent	prevent	VB	O
intracellular	intracellular	JJ	O
H+	H+	NNP	O
accumulation	accumulation	NN	O
cancer	cancer	NN	O
cells	cell	NNS	O
upregulates	upregulate	VBZ	O
proton	proton	NNP	O
exchangers	exchanger	NNS	O
that	that	WDT	O
extrude	extrude	VBP	O
protons	proton	NNS	O
in	in	IN	O
excess	excess	JJ	O
contributing	contributing	NN	O
to	to	TO	O
acidify	acidify	NNP	O
extracellular	extracellular	NNP	O
tumour	tumour	NN	O
microenvironment	microenvironment	JJ	B
,	,	,	B
,	,	,	B
.	.	.	O

Among	among	IN	O
these	these	DT	O
proton	proton	NNP	O
exchangers	exchanger	NNS	O
,	,	,	O
a	a	DT	O
primary	primary	JJ	O
role	role	NN	O
is	be	VBZ	O
played	play	VBN	O
by	by	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
,	,	,	O
an	an	DT	O
enzyme	enzyme	NNS	O
overexpressed	overexpresse	VBN	O
in	in	IN	O
many	many	JJ	O
types	type	NNS	O
of	of	IN	O
cancers	cancer	NNS	O
,	,	,	O
including	include	VBG	O
prostate	prostate	NN	O
cancer	cancer	NN	O
,	,	,	O
with	with	IN	O
the	the	DT	O
potential	potential	NN	O
to	to	TO	O
represent	represent	VB	O
both	both	CC	O
a	a	DT	O
promising	promising	JJ	O
tumour	tumour	NN	O
biomarker	biomarker	NN	O
and	and	CC	O
a	a	DT	O
specific	specific	JJ	O
target	target	NN	O
for	for	IN	O
future	future	JJ	O
cancer	cancer	NN	O
therapies	therapy	NNS	B
,	,	,	B
,	,	,	B
,	,	,	B
.	.	.	O

Under	under	IN	O
the	the	DT	O
pressure	pressure	NN	O
of	of	IN	O
the	the	DT	O
acidic	acidic	JJ	O
microenvironment	microenvironment	NN	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
are	be	VBP	O
upregulated	upregulated	JJ	O
in	in	IN	O
both	both	DT	O
tumour	tumour	NN	O
cells	cell	NNS	B
,	,	,	B
and	and	CC	O
the	the	DT	O
exosomes	exosome	NNS	O
released	release	VBN	O
extracellularly	extracellularly	RB	B
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
support	support	VB	O
a	a	DT	O
real	real	JJ	O
clinical	clinical	JJ	O
impact	impact	NN	O
of	of	IN	O
the	the	DT	O
previous	previous	JJ	O
information	information	NN	O
,	,	,	O
we	-PRON-	PRP	O
performed	perform	VBD	O
a	a	DT	O
pilot	pilot	NN	O
clinical	clinical	JJ	O
study	study	NN	O
in	in	IN	O
which	which	WDT	O
exosomes	exosome	VBZ	O
purified	purify	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
patients	patient	NNS	O
have	have	VBP	O
been	be	VBN	O
compared	compare	VBN	O
to	to	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
from	from	IN	O
healthy	healthy	JJ	O
controls	control	NNS	O
.	.	.	O

We	-PRON-	PRP	O
analysed	analyse	VBD	O
the	the	DT	O
expression	expression	NN	O
and	and	CC	O
function	function	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
in	in	IN	O
plasmatic	plasmatic	JJ	O
samples	sample	NNS	O
,	,	,	O
hypothesising	hypothesise	VBG	O
that	that	IN	O
this	this	DT	O
was	be	VBD	O
related	relate	VBN	O
to	to	IN	O
the	the	DT	O
decreased	decreased	JJ	O
intraluminal	intraluminal	JJ	O
pH.	ph.	NN	O
The	the	DT	O
results	result	NNS	O
of	of	IN	O
this	this	DT	O
study	study	NN	O
show	show	NN	O
for	for	IN	O
the	the	DT	O
first	first	JJ	O
time	time	NN	O
that	that	WDT	O
exosomes	exosome	VBZ	O
purified	purify	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
patients	patient	NNS	O
with	with	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
express	express	VBP	O
significantly	significantly	RB	O
higher	high	JJR	O
levels	level	NNS	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
,	,	,	O
through	through	IN	O
different	different	JJ	O
methodological	methodological	JJ	O
approaches	approach	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
western	western	JJ	O
blot	blot	NN	O
analysis	analysis	NN	O
,	,	,	O
in	in	IN	O
both	both	CC	O
the	the	DT	O
whole	whole	JJ	O
exosome	exosome	NN	O
lysates	lysate	NNS	O
and	and	CC	O
sucrose	sucrose	JJ	O
gradients	gradient	NNS	O
,	,	,	O
and	and	CC	O
immunocapture	immunocapture	VB	O
based	base	VBN	O
ELISA	ELISA	NNP	O
;	;	:	O
the	the	DT	O
increased	increase	VBN	O
CA	CA	NNP	O
IX	IX	NNP	O
exosome	exosome	JJ	O
expression	expression	NN	O
corresponded	correspond	VBD	O
to	to	IN	O
a	a	DT	O
real	real	JJ	O
function	function	NN	O
inasmuch	inasmuch	JJ	O
as	as	IN	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
patients	patient	NNS	O
with	with	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
showed	show	VBD	O
a	a	DT	O
significantly	significantly	RB	O
higher	high	JJR	O
CA	ca	NN	O
-	-	HYPH	O
activity	activity	NN	O
;	;	:	O
exosomes	exosome	NNS	O
purified	purify	VBN	O
from	from	IN	O
plasma	plasma	NN	O
of	of	IN	O
patients	patient	NNS	O
with	with	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
are	be	VBP	O
acidic	acidic	JJ	O
,	,	,	O
as	as	IN	O
shown	show	VBN	O
by	by	IN	O
Nanoscale	Nanoscale	NNP	O
Flow	Flow	NNP	O
Cytometry	Cytometry	NNP	O
and	and	CC	O
CA	CA	NNP	O
-	-	HYPH	O
IX	IX	NNP	O
,	,	,	O
exosome	exosome	JJ	O
markers	marker	NNS	O
and	and	CC	O
intraluminal	intraluminal	JJ	O
low	low	JJ	O
pH	pH	NNP	O
co	co	NN	O
-	-	NN	O
localize	localize	JJ	O
in	in	IN	O
exosome	exosome	NNP	O
released	release	VBN	O
by	by	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
cells	cell	NNS	O
in	in	IN	O
acidic	acidic	JJ	O
conditions	condition	NNS	O
,	,	,	O
as	as	IN	O
shown	show	VBN	O
by	by	IN	O
confocal	confocal	JJ	O
microscopy	microscopy	NN	O
.	.	.	O

A	a	DT	O
significant	significant	JJ	O
difference	difference	NN	O
in	in	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
was	be	VBD	O
that	that	IN	O
circulating	circulate	VBG	O
exosomes	exosome	NNS	O
of	of	IN	O
cancer	cancer	NN	O
patients	patient	NNS	O
expressed	express	VBD	O
a	a	DT	O
double	double	JJ	O
band	band	NN	O
at	at	IN	O
58/54âkDa	58/54âkda	CD	O
,	,	,	O
suggesting	suggest	VBG	O
the	the	DT	O
occurrence	occurrence	NN	O
of	of	IN	O
post	post	JJ	O
-	-	JJ	O
transcriptional	transcriptional	JJ	O
changes	change	NNS	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
induced	induce	VBN	O
by	by	IN	O
the	the	DT	O
tumour	tumour	NN	O
condition	condition	NN	O
.	.	.	O

All	all	RB	O
in	in	IN	O
all	all	DT	O
our	-PRON-	PRP$	O
study	study	NN	O
shows	show	VBZ	O
for	for	IN	O
the	the	DT	O
first	first	JJ	O
time	time	NN	O
a	a	DT	O
correlation	correlation	NN	O
between	between	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
intraluminal	intraluminal	JJ	O
acidity	acidity	NN	O
in	in	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
of	of	IN	O
cancer	cancer	NN	O
patients	patient	NNS	O
.	.	.	O

Confocal	confocal	JJ	O
microscopy	microscopy	JJ	O
showed	show	VBD	O
that	that	IN	O
a	a	DT	O
high	high	JJ	O
intracellular	intracellular	JJ	O
acidity	acidity	NN	O
characterises	characterise	NNS	O
prostate	prostate	NN	O
cancer	cancer	NN	O
cells	cell	NNS	O
stably	stably	RB	O
cultured	culture	VBD	O
at	at	IN	O
pH	pH	NNP	O
6.5	6.5	CD	O
,	,	,	O
as	as	IN	O
demonstrated	demonstrate	VBN	O
by	by	IN	O
the	the	DT	O
massive	massive	JJ	O
intake	intake	NN	O
of	of	IN	O
BCECF	BCECF	NNP	O
in	in	IN	O
these	these	DT	O
cells	cell	NNS	O
;	;	:	O
this	this	DT	O
was	be	VBD	O
consistent	consistent	JJ	O
with	with	IN	O
a	a	DT	O
clear	clear	JJ	O
co	co	NN	O
-	-	NN	O
localization	localization	NN	O
of	of	IN	O
the	the	DT	O
exosomal	exosomal	JJ	O
marker	marker	NN	O
CD9	CD9	NNP	O
and	and	CC	O
CA	CA	NNP	O
IX	IX	NNP	O
,	,	,	O
mainly	mainly	RB	O
at	at	IN	O
the	the	DT	O
plasma	plasma	NN	O
membrane	membrane	NN	O
,	,	,	O
while	while	IN	O
co	co	NNS	O
-	-	VBN	O
expressed	express	VBN	O
at	at	IN	O
the	the	DT	O
cytoplasm	cytoplasm	NN	O
and	and	CC	O
the	the	DT	O
nuclear	nuclear	JJ	O
membrane	membrane	NN	O
levels	level	NNS	O
,	,	,	O
as	as	RB	O
well	well	RB	O
.	.	.	O

The	the	DT	O
concentration	concentration	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
/	/	SYM	O
CD9	CD9	NNP	O
/	/	SYM	O
acidic	acidic	JJ	O
particles	particle	NNS	O
at	at	IN	O
the	the	DT	O
plasma	plasma	NN	O
membrane	membrane	NN	O
suggests	suggest	VBZ	O
an	an	DT	O
increased	increased	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
endosomal	endosomal	JJ	O
compartment	compartment	NN	O
,	,	,	O
in	in	IN	O
turn	turn	NN	O
,	,	,	O
leading	lead	VBG	O
to	to	TO	O
exosome	exosome	VB	O
formation	formation	NN	O
and	and	CC	O
extracellular	extracellular	NNP	O
release	release	NN	O
.	.	.	O

These	these	DT	O
results	result	NNS	O
indicate	indicate	VBP	O
that	that	IN	O
tumour	tumour	NN	O
acidic	acidic	JJ	O
microenvironment	microenvironment	NN	O
is	be	VBZ	O
the	the	DT	O
crucial	crucial	JJ	O
factor	factor	NN	O
in	in	IN	O
affecting	affect	VBG	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
in	in	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
cells	cell	NNS	O
and	and	CC	O
cancer	cancer	NN	O
-	-	HYPH	O
released	release	VBN	O
exosomes	exosome	NNS	O
.	.	.	O

It	-PRON-	PRP	O
appears	appear	VBZ	O
conceivable	conceivable	JJ	O
that	that	IN	O
the	the	DT	O
microenvironmental	microenvironmental	JJ	O
tumour	tumour	NN	O
acidity	acidity	NN	O
may	may	MD	O
increase	increase	VB	O
exosomes	exosome	VBZ	O
release	release	NN	O
,	,	,	O
together	together	RB	O
with	with	IN	O
the	the	DT	O
upregulation	upregulation	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
in	in	IN	O
PCa	PCa	NNS	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
the	the	DT	O
increase	increase	NN	O
of	of	IN	O
plasmatic	plasmatic	JJ	O
levels	level	NNS	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
/	/	SYM	O
acidic	acidic	JJ	O
exosomes	exosome	NNS	O
in	in	IN	O
prostate	prostate	NN	O
cancer	cancer	NN	O
patients	patient	NNS	O
may	may	MD	O
be	be	VB	O
the	the	DT	O
result	result	NN	O
of	of	IN	O
the	the	DT	O
spill	spill	NN	O
-	-	HYPH	O
over	over	NN	O
of	of	IN	O
these	these	DT	O
exosomes	exosome	NNS	O
from	from	IN	O
the	the	DT	O
tumour	tumour	NN	O
to	to	IN	O
the	the	DT	O
bloodstream	bloodstream	NN	O
.	.	.	O

Indeed	indeed	RB	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
a	a	DT	O
transmembrane	transmembrane	JJ	O
protein	protein	NN	O
whose	whose	WP$	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
exhibits	exhibit	VBZ	O
the	the	DT	O
fundamental	fundamental	JJ	O
biochemical	biochemical	JJ	O
and	and	CC	O
biophysical	biophysical	JJ	O
properties	property	NNS	O
that	that	WDT	O
allow	allow	VBP	O
stability	stability	NN	O
and	and	CC	O
activity	activity	NN	O
at	at	IN	O
low	low	JJ	O
pH	pH	NNP	B
,	,	,	B
.	.	.	O

Conversely	conversely	RB	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
is	be	VBZ	O
down	down	RB	O
-	-	HYPH	O
regulated	regulated	JJ	O
in	in	IN	O
healthy	healthy	JJ	O
donors	donor	NNS	O
plasma	plasma	NN	O
exosomes	exosome	NNS	O
since	since	IN	O
under	under	IN	O
normal	normal	JJ	O
conditions	condition	NNS	O
,	,	,	O
the	the	DT	O
cells	cell	NNS	O
donât	donât	VBP	O
need	need	VBP	O
a	a	DT	O
high	high	JJ	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
proton	proton	NNP	O
exchangers	exchanger	NNS	O
because	because	IN	O
they	-PRON-	PRP	O
use	use	VBP	O
oxidative	oxidative	JJ	O
metabolism	metabolism	NN	O
.	.	.	O

The	the	DT	O
key	key	JJ	O
role	role	NN	O
of	of	IN	O
the	the	DT	O
acidic	acidic	JJ	O
tumour	tumour	NN	O
microenvironment	microenvironment	NN	O
in	in	IN	O
increasing	increase	VBG	O
the	the	DT	O
release	release	NN	O
of	of	IN	O
exosome	exosome	NN	O
by	by	IN	O
cancer	cancer	NN	O
cells	cell	NNS	O
support	support	VBP	O
our	-PRON-	PRP$	O
previous	previous	JJ	O
studies	study	NNS	B
,	,	,	B
,	,	,	B
,	,	,	B
.	.	.	O

Our	-PRON-	PRP$	O
study	study	NN	O
supports	support	VBZ	O
a	a	DT	O
new	new	JJ	O
idea	idea	NN	O
for	for	IN	O
providing	provide	VBG	O
reliable	reliable	JJ	O
tumour	tumour	NN	O
markers	marker	NNS	O
suitable	suitable	JJ	O
for	for	IN	O
clinical	clinical	JJ	O
use	use	NN	O
.	.	.	O

Here	here	RB	O
,	,	,	O
we	-PRON-	PRP	O
have	have	VBP	O
shown	show	VBN	O
that	that	IN	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
from	from	IN	O
cancer	cancer	NN	O
patients	patient	NNS	O
overexpress	overexpress	NN	O
CA	CA	NNP	O
IX	IX	NNP	O
and	and	CC	O
together	together	RB	O
with	with	IN	O
exerting	exert	VBG	O
a	a	DT	O
CA	CA	NNP	O
IX	ix	NN	O
-	-	HYPH	O
related	relate	VBN	O
activity	activity	NN	O
.	.	.	O

This	this	DT	O
is	be	VBZ	O
probably	probably	RB	O
the	the	DT	O
first	first	JJ	O
translational	translational	JJ	O
evidence	evidence	NN	O
in	in	IN	O
this	this	DT	O
sense	sense	NN	O
;	;	:	O
that	that	DT	O
is	be	VBZ	O
the	the	DT	O
expression	expression	NN	O
of	of	IN	O
a	a	DT	O
protein	protein	NN	O
plus	plus	CC	O
the	the	DT	O
activity	activity	NN	O
related	relate	VBN	O
to	to	IN	O
the	the	DT	O
expressed	express	VBN	O
protein	protein	NN	O
,	,	,	O
may	may	MD	O
represent	represent	VB	O
a	a	DT	O
new	new	JJ	O
and	and	CC	O
non	non	JJ	O
-	-	JJ	O
invasive	invasive	JJ	O
diagnostic	diagnostic	JJ	O
tool	tool	NN	O
with	with	IN	O
a	a	DT	O
potentially	potentially	RB	O
high	high	JJ	O
clinical	clinical	JJ	O
impact	impact	NN	O
in	in	IN	O
early	early	JJ	O
diagnosis	diagnosis	NN	O
and	and	CC	O
monitoring	monitoring	NN	O
of	of	IN	O
prostatic	prostatic	JJ	O
cancer	cancer	NN	O
,	,	,	O
but	but	CC	O
conceivably	conceivably	RB	O
all	all	DT	O
malignant	malignant	JJ	O
tumours	tumour	NNS	O
as	as	RB	O
well	well	RB	O
.	.	.	O

